Jump to content

AXA/2025/FY/Earnings presentation: Difference between revisions

From Insurer Brain
< AXA
Content deleted Content added
doc_archive: publish snjra2xp9r (.md link)
doc_archive: publish snjra2xp9r
Line 10: Line 10:
| pages = 49
| pages = 49
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/abwhxx5fn6DF3AUJ_AXA_Full_Year_Results_2025b.pdf
| summary_md = File:AXA-2025-FY-Earnings_presentation.md
| summary_md = <!-- ARCHIVE_MD_LINK_HERE -->
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
| intro_sentence = This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).
| wide = yes
| wide = yes
Line 19: Line 19:
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).''
''This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).''


=== Full Year 2025 Earnings Presentation ===
=== Full Year 2025 Earnings Presentation February 26, 2026 ===

{{chunk|doc=snjra2xp9r|c=1|p=1}}
====== Presentation date ======

* The presentation date is February 26, [[Definition:Year 2026|2026]].


=== Full Year 2025 Earnings ===
=== Full Year 2025 Earnings ===


{{chunk|doc=snjra2xp9r|c=2|p=2}}
{{chunk|doc=snjra2xp9r|c=1|p=2}}
====== Legal and cautionary statements ======
====== Legal and cautionary statements ======


* Certain statements in the presentation are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and other non-historical information.
* Certain statements in this document are forward-looking, identified by words like "expects," "anticipates," "may," "plan," "target," "would," and "could".
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking and provide one-off guidance for the last year of the Group’s current strategic plan.
* Forward-looking statements are identified by words like "expects", "anticipates", "may", "plan," "target", "would", and "could".
* Forward-looking statements are based on Management’s current views and intentions, are subject to change, and carry known and unknown risks and uncertainties outside AXA’s control that could cause actual results to differ materially.
* Statements regarding expected [[Definition:Underlying earnings per share|underlying earnings per share]] (UEPS) growth for [[Definition:Year 2026|2026]] are forward-looking statements providing one-off guidance for the last year of the Group’s current strategic plan.
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by law.
* These statements are based on Management’s current views and intentions and are subject to change.
* This presentation refers to non-GAAP financial measures (APMs) used by Management for analyzing operating trends, financial performance, and position.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties outside AXA’s control, which can cause actual results to differ materially.
* Non-GAAP financial measures generally lack standardized meaning and may not be comparable to measures used by other companies.
* Each forward-looking statement is valid only at the date of the presentation.
* For important factors, risks, and uncertainties affecting AXA’s business and/or results, refer to Part 5 - “Risk Factors and Risk Management” of AXA’s Universal Registration Document for the year ended December 31, 2024 (the “2024 Universal Registration Document”).
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations.
* The presentation refers to non-GAAP financial measures, or alternative performance measures (APMs), used by Management for analyzing operating trends, financial performance, and position.
* These non-GAAP financial measures generally have no standardized meaning and may not be comparable to measures used by other companies.
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
* Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
* "[[Definition:Underlying earnings|Underlying earnings]]", UEPS (“underlying earnings per share”), “underlying return on equity”, “combined ratio”, and “debt gearing” are APMs as defined in ESMA’s guidelines and the AMF’s related position statement issued in 2015.
* "[[Definition:Underlying earnings|Underlying earnings]]," UEPS, "underlying return on equity," "combined ratio," and "debt gearing" are APMs as defined by ESMA’s guidelines and AMF’s position statement.
* AXA provides a reconciliation of APMs to related financial statement items and/or their calculation methodology in its Activity Report as of December 31, 2025 (“AXA’s 2025 Activity Report”), under the heading “USE OF NON-GAAP AND ALTERNATIVE PERFORMANCE MEASURES”.
* Reconciliations of APMs to IFRS financial statements and their calculation methodologies are provided in AXA’s 2025 Activity Report.
* AXA’s 2025 Activity Report is available on www.axa.com.
* Further information on non-GAAP financial measures is available in the Glossary in AXA’s 2025 Activity Report.
* AXA’s Activity Report as of December 31, 2025, is available on the AXA Group website (www.axa.com).
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to audit completion.
* AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA’s statutory auditors.


=== Contents ===
{{chunk|doc=snjra2xp9r|c=3|p=3}}
====== Presentation structure and speakers ======


{{chunk|doc=snjra2xp9r|c=2|p=3}}
* The presentation includes "[[Definition:Full year 2025|FY25]] Highlights" on page 04, presented by Thomas Buberl, Group CEO.
====== Presentation contents and speakers ======
* "FY25 Business Performance" is on page 09, presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology.

* "FY25 Financial Performance" is on page 13, presented by Alban de Mailly Nesle, Group CFO.
* [[Definition:Full year 2025|FY25]] Highlights are on p.04.
* Thomas Buberl is the Group CEO.
* FY25 Business Performance is on p.09.
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
* FY25 Financial Performance is on p.13.
* Alban de Mailly Nesle is the Group CFO.


== FY25 Highlights ==
== FY25 Highlights ==


{{chunk|doc=snjra2xp9r|c=4|p=4}}
{{chunk|doc=snjra2xp9r|c=3|p=4}}
====== Group CEO ======
====== Group CEO ======


Line 64: Line 59:
=== Full Year 2025 – Excellent performance ===
=== Full Year 2025 – Excellent performance ===


{{chunk|doc=snjra2xp9r|c=5|p=5}}
{{chunk|doc=snjra2xp9r|c=4|p=5}}
====== Financial performance FY25 ======
====== Financial performance highlights ======


* Revenues +6% vs. [[Definition:Full year 2024|FY24]]
* Revenues: +6% vs. [[Definition:Full year 2024|FY24]]
* [[Definition:Underlying earnings per share|Underlying EPS]] +8% vs. FY24
* [[Definition:Underlying earnings per share|Underlying EPS]]: +8% vs. FY24
* ROE 16% [[Definition:Full year 2025|FY25]]
* ROE: 16% in [[Definition:Full year 2025|FY25]]
* Solvency II ratio 224% FY25
* Solvency II ratio: 224% in FY25


{{chunk|doc=snjra2xp9r|c=6|p=5}}
{{chunk|doc=snjra2xp9r|c=5|p=5}}
====== Shareholder returns and future outlook ======
====== Shareholder returns and outlook ======


* DPS growth: +8%
* Delivering value for shareholders with +8% DPS growth and EUR 1.25bn annual [[Definition:Share buyback|share buyback]]
* Annual [[Definition:Share buyback|share buyback]]: EUR 1.25bn
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]]
* Confident to deliver [[Definition:Underlying earnings per share|underlying EPS]] growth at the upper end of the 6%-8% [[Definition:Target range|target range]] for [[Definition:Year 2026|2026]]


{{chunk|doc=snjra2xp9r|c=7|p=5}}
{{chunk|doc=snjra2xp9r|c=6|p=5}}
====== Full Year 2025 – Excellent performance ======
====== Full Year 2025 – Excellent performance ======


Line 86: Line 82:
=== Executing the plan on growth, margin and efficiency ===
=== Executing the plan on growth, margin and efficiency ===


{{chunk|doc=snjra2xp9r|c=8|p=6}}
{{chunk|doc=snjra2xp9r|c=7|p=6}}
====== Underlying earnings by FY24, FY25, Change ======
====== Underlying earnings by FY ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 108: Line 104:
|}
|}
</div>
</div>

* High organic growth: +6% top line growth, well balanced across lines (P&amp;C: +5%, Life: +9%, Health: +5%)
{{chunk|doc=snjra2xp9r|c=8|p=6}}
* Record profitability: Further margin expansion in P&amp;C and L&amp;H; improvement in efficiency
====== Organic growth, profitability, and efficiency ======
* Scaling the business: Continued investments in growth and technology

* Consistent earnings growth while enhancing reserve prudence
* Top line growth: +6% organic.
* Growth balanced across lines: P&C +5%, Life +9%, Health +5%.
* Record profitability with further margin expansion in P&C and L&H.
* Improved efficiency.
* Continued investments in growth and technology for scaling the business.
* Consistent earnings growth while enhancing reserve prudence.

{{chunk|doc=snjra2xp9r|c=9|p=6}}
====== Executing the plan on growth, margin and efficiency ======


{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}}
{{fn note|1=1|2=Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.}}
Line 119: Line 124:
==== Secular trends fueling demand across businesses ====
==== Secular trends fueling demand across businesses ====


{{chunk|doc=snjra2xp9r|c=9|p=7}}
{{chunk|doc=snjra2xp9r|c=10|p=7}}
====== Protection gaps and emerging risks ======

* Protection gaps and emerging corporate risks are secular trends fueling demand across businesses.
* Demographics are driving demand for private retirement and healthcare.

{{chunk|doc=snjra2xp9r|c=11|p=7}}
====== Share by segment ======
====== Share by segment ======


Line 136: Line 147:
| style="text-align:left" | Large &amp; Specialty
| style="text-align:left" | Large &amp; Specialty
| style="text-align:right" | 17%
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME &amp; Mid-market
| style="text-align:right" | 16%
|-
|-
| style="text-align:left" | Retail
| style="text-align:left" | Retail
| style="text-align:right" | 17%
| style="text-align:right" | 17%
|-
| style="text-align:left" | SME &amp; Mid-market
| style="text-align:right" | 16%
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=10|p=7}}
{{chunk|doc=snjra2xp9r|c=12|p=7}}
====== Secular trends fueling demand ======
====== Secular trends fueling demand ======


* Secular trends are fueling demand across businesses.
* Protection gaps and emerging corporate risks are driving demand.
* Demographics are driving demand for private retirement and healthcare.


==== Our right to win ====
==== Our right to win ====


{{chunk|doc=snjra2xp9r|c=11|p=7}}
{{chunk|doc=snjra2xp9r|c=13|p=7}}
====== Competitive advantages ======
====== Right to win ======


* Leading brand and high customer NPS
* Leading brand and high customer NPS
* Strong and diversified distribution
* Strong and diversified distribution
* Technical expertise in pricing and underwriting risks
* Technical expertise in pricing and underwriting risks
* Scale offering cost advantage
* Scale offering a cost advantage


{{chunk|doc=snjra2xp9r|c=12|p=7}}
{{chunk|doc=snjra2xp9r|c=14|p=7}}
====== Our right to win ======
====== Our right to win ======


Line 168: Line 178:
=== Laying the foundation for the next plan ===
=== Laying the foundation for the next plan ===


{{chunk|doc=snjra2xp9r|c=13|p=8}}
{{chunk|doc=snjra2xp9r|c=15|p=8}}
====== Strategic priorities ======
====== Strategic priorities ======


Line 179: Line 189:
== FY25 Business Performance ==
== FY25 Business Performance ==


{{chunk|doc=snjra2xp9r|c=14|p=9}}
{{chunk|doc=snjra2xp9r|c=16|p=9}}
====== Executive roles ======
====== FY25 Business Performance ======


* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
* Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
Line 186: Line 196:
=== Strong delivery across our businesses ===
=== Strong delivery across our businesses ===


{{chunk|doc=snjra2xp9r|c=15|p=10}}
{{chunk|doc=snjra2xp9r|c=17|p=10}}
====== Gross written premiums & Underlying earnings by geography ======
====== Gross written premiums & Underlying earnings by geography ======


Line 195: Line 205:
! style="text-align:right" | Gross written premiums
! style="text-align:right" | Gross written premiums
! style="text-align:right" | Underlying earnings
! style="text-align:right" | Underlying earnings
|-
| style="text-align:left" | France (27% of total GWP{{fn ref|1}})
| style="text-align:right" | +6% to €31bn
| style="text-align:right" | +7% to €2.2bn
|-
| style="text-align:left" | Europe (38% of total GWP{{fn ref|1}})
| style="text-align:right" | +6% to €43bn
| style="text-align:right" | +9% to €3.5bn
|-
| style="text-align:left" | AXA XL (17% of total GWP{{fn ref|1}})
| style="text-align:right" | +4% to €19bn
| style="text-align:right" | +9% to €1.9bn
|-
| style="text-align:left" | Asia, Africa &amp; EME-LATAM (18% of total GWP{{fn ref|1}})
| style="text-align:right" | +13% to €20bn
| style="text-align:right" | +6% to €1.5bn
|}
|}
</div>
</div>
<tr><td>France (27% of total [[Definition:Gross written premiums|GWP]]{{fn ref|1}})</td><td>+6% to €31bn</td><td>+7% to €2.2bn</td></tr>
<tr><td>Europe (38% of total GWP{{fn ref|1}})</td><td>+6% to €43bn</td><td>+9% to €3.5bn</td></tr>
<tr><td>AXA XL (17% of total GWP{{fn ref|1}})</td><td>+4% to €19bn</td><td>+9% to €1.9bn</td></tr>
<tr><td>Asia, Africa & EME-LATAM (18% of total GWP{{fn ref|1}})</td><td>+13% to €20bn</td><td>+6% to €1.5bn</td></tr>
</table>


{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}
{{fn note|1=1|2=FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.}}
Line 207: Line 228:
=== P&C – Strong margins, confidence in sustaining growth ===
=== P&C – Strong margins, confidence in sustaining growth ===


{{chunk|doc=snjra2xp9r|c=16|p=11}}
{{chunk|doc=snjra2xp9r|c=18|p=11}}
====== Gross written premiums ======
====== P&C GWP and earnings ======


* [[Definition:Gross written premiums|Gross Written Premiums]] (GWP) were EUR 58bn.
* [[Definition:Gross written premiums|GWP]]: EUR 58bn
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty).
* GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty)
* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn


{{chunk|doc=snjra2xp9r|c=17|p=11}}
{{chunk|doc=snjra2xp9r|c=19|p=11}}
====== 2025 and Beyond ======
====== Outlook by business segment ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 233: Line 255:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=18|p=11}}
{{chunk|doc=snjra2xp9r|c=20|p=11}}
====== Underlying earnings and efficiency ======
====== Future strategic focus ======


* [[Definition:Underlying earnings|Underlying earnings]]: +9% to EUR 5.9bn
* Continued progress on efficiency
* Continued progress on efficiency
* Higher investment income
* Higher investment income
* Data & AI to further enhance customer experience & technical excellence
* Data & AI to further enhance customer experience & technical excellence


{{chunk|doc=snjra2xp9r|c=19|p=11}}
{{chunk|doc=snjra2xp9r|c=21|p=11}}
====== P&C – Strong margins, confidence in sustaining growth ======
====== P&C – Strong margins, confidence in sustaining growth ======


Line 249: Line 270:
=== L&H – Good momentum, well positioned to capture growth opportunities ===
=== L&H – Good momentum, well positioned to capture growth opportunities ===


{{chunk|doc=snjra2xp9r|c=20|p=12}}
{{chunk|doc=snjra2xp9r|c=22|p=12}}
====== GWP by Short-term and Long-term ======
====== GWP by short-term and long-term ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 256: Line 277:
|-
|-
| style="text-align:left" | Short-term
| style="text-align:left" | Short-term
| style="text-align:right" | Long-term
| style="text-align:right" |
|-
| style="text-align:left" | Long-term
| style="text-align:right" |
|-
| style="text-align:left" | Total GWP
| style="text-align:right" | €57bn
|}
|}
</div>
</div>

{{chunk|doc=snjra2xp9r|c=23|p=12}}
====== Underlying earnings ======

* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn


==== 2025 Beyond 2025 ====
==== 2025 Beyond 2025 ====


{{chunk|doc=snjra2xp9r|c=21|p=12}}
{{chunk|doc=snjra2xp9r|c=24|p=12}}
====== Strategic priorities for 2025 and Beyond 2025 ======
====== Strategic priorities ======


* Long-term business:
* Long-term business: Accelerating net flows in Savings at attractive margins.
* Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for customers.
** 2025: Accelerating net flows in Savings at attractive margins
* Short-term business: Growing technical results while absorbing Mexico VAT impact.
** Beyond 2025: Capturing savings & retirement opportunity, sourcing best asset management products for customers
* Short-term business:
* Short-term business: Capitalizing on demand for health & protection while further improving margins.
* Focus on cost reduction.
** 2025: Growing technical results while absorbing Mexico VAT impact
* Increasing penetration of Protection riders in Savings offerings.
** Beyond 2025: Capitalizing on demand for health & protection while further improving margins
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health.
* [[Definition:Underlying earnings|Underlying earnings]] +7% to EUR 3.5bn
* Focus on cost reduction
* Increasing penetration of Protection riders in Savings offerings
* Leveraging AI to reduce claims leakage & improve customer outcomes in Health


{{chunk|doc=snjra2xp9r|c=22|p=12}}
{{chunk|doc=snjra2xp9r|c=25|p=12}}
====== 2025 Beyond 2025 ======
====== 2025 Beyond 2025 ======


{{fn note|1=1|2=Change FY25 vs. FY24 at constant FX.}}
{{fn note|1=1|2=1. Change FY25 vs. FY24 at constant FX.}}


== FY25 Financial Performance ==
== FY25 Financial Performance ==


{{chunk|doc=snjra2xp9r|c=23|p=13}}
{{chunk|doc=snjra2xp9r|c=26|p=13}}
====== Group CFO ======
====== Group CFO ======


Line 290: Line 319:
=== P&C – Continued disciplined growth ===
=== P&C – Continued disciplined growth ===


{{chunk|doc=snjra2xp9r|c=24|p=14}}
{{chunk|doc=snjra2xp9r|c=27|p=14}}
====== Currency notation ======
====== Currency notation ======


Line 297: Line 326:
==== GWP & Other Revenues ====
==== GWP & Other Revenues ====


{{chunk|doc=snjra2xp9r|c=25|p=14}}
{{chunk|doc=snjra2xp9r|c=28|p=14}}
====== GWP & other revenues by lines of business ======
====== GWP & other revenues by segment ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t6" class="wikitable fintable"
{| id="t6" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
Line 311: Line 340:
|-
|-
| style="text-align:left" | Commercial lines
| style="text-align:left" | Commercial lines
| rowspan="3" style="text-align:right" | 56.5
| style="text-align:right" |
| style="text-align:right" | 35.8
| style="text-align:right" | 35.8
| style="text-align:right" | +4%
| style="text-align:right" | +4%
Line 318: Line 347:
|-
|-
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:left" | AXA XL Reinsurance
| style="text-align:right" |
| style="text-align:right" | 2.6
| style="text-align:right" | 2.6
| style="text-align:right" | +8%
| style="text-align:right" | +8%
Line 324: Line 354:
|-
|-
| style="text-align:left" | Retail lines
| style="text-align:left" | Retail lines
| style="text-align:right" |
| style="text-align:right" | 19.7
| style="text-align:right" | 19.7
| style="text-align:right" | +7%
| style="text-align:right" | +7%
Line 338: Line 369:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=26|p=14}}
{{chunk|doc=snjra2xp9r|c=29|p=14}}
====== Commercial lines growth drivers ======
====== Commercial lines growth drivers ======


* Continued pricing momentum and volume growth in Mid-market and SME.
* Continued pricing momentum and volume growth in Mid-market and SME
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance.
* Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance
* Growth supported by alternative capital.
* Growth supported by alternative capital
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]]).
* Favorable pricing trends and strong growth in net new contracts (+1.7m in [[Definition:Full year 2025|FY25]])


{{chunk|doc=snjra2xp9r|c=27|p=14}}
{{chunk|doc=snjra2xp9r|c=30|p=14}}
====== GWP & Other Revenues ======
====== GWP & Other Revenues ======


Line 356: Line 387:
==== Combined ratio ====
==== Combined ratio ====


{{chunk|doc=snjra2xp9r|c=28|p=15}}
{{chunk|doc=snjra2xp9r|c=31|p=15}}
====== Combined ratio ======
====== Combined ratio ======


Line 366: Line 397:
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | Combined ratio (total)
| style="text-align:left" | Combined ratio
| style="text-align:right" | 91.0%
| style="text-align:right" | 91.0%
| style="text-align:right" | 90.6%
| style="text-align:right" | 90.6%
Line 392: Line 423:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=29|p=15}}
{{chunk|doc=snjra2xp9r|c=32|p=15}}
====== Combined ratio drivers ======
====== Combined ratio drivers ======


* Undiscounted current year loss ratio improved, excluding Nat Cat.
* Undiscounted current year loss ratio improved, excluding Nat Cat.
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
* Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
* AXA XL Insurance margins stable at attractive levels, reflecting disciplined cycle management.
* AXA XL Insurance margins stable at attractive levels due to disciplined cycle management.
* Expense ratio improved due to efficiency measures, while continuing investment in growth initiatives and technology.
* Expense ratio improved due to efficiency measures, while investing in growth initiatives and technology.


{{chunk|doc=snjra2xp9r|c=30|p=15}}
{{chunk|doc=snjra2xp9r|c=33|p=15}}
====== Nat Cat and reserve management ======
====== Nat Cat and reserve development ======


* Nat Cat charges were below the normalized load.
* Nat Cat charges were below the normalized load.
Line 409: Line 440:
=== P&C – Earnings growth from higher underwriting and financial result ===
=== P&C – Earnings growth from higher underwriting and financial result ===


{{chunk|doc=snjra2xp9r|c=31|p=16}}
{{chunk|doc=snjra2xp9r|c=34|p=16}}
====== P&C earnings growth ======
====== P&C earnings overview ======


* P&C earnings grew by EUR 0.2bn to EUR 7.6bn in 2023.
* P&C earnings increased by EUR 0.2bn to EUR 4.2bn.
* This growth was driven by a higher underwriting result and a higher financial result.
* This growth was driven by higher underwriting results and a higher financial result.


{{chunk|doc=snjra2xp9r|c=32|p=16}}
{{chunk|doc=snjra2xp9r|c=35|p=16}}
====== Underlying earnings waterfall by step ======
====== Underlying earnings by step ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 427: Line 458:
| style="text-align:right" | 5,510
| style="text-align:right" | 5,510
|-
|-
| style="text-align:left" | Volume growth
| style="text-align:left" | Volume growth ( Underwriting result{{fn ref|1}})
| style="text-align:right" | +292
| style="text-align:right" | +292
|-
|-
Line 433: Line 464:
| style="text-align:right" | +189
| style="text-align:right" | +189
|-
|-
| style="text-align:left" | Investment income
| style="text-align:left" | Investment income ( Financial result)
| style="text-align:right" | +435
| style="text-align:right" | +435
|-
|-
| style="text-align:left" | Insurance finance expenses
| style="text-align:left" | Insurance finance expenses
| style="text-align:right" | -235
| style="text-align:right" | -235
|-
|-
Line 450: Line 481:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=33|p=16}}
{{chunk|doc=snjra2xp9r|c=36|p=16}}
====== P&C earnings growth ======
====== P&C earnings growth drivers ======


* P&C earnings grew +9%.
* P&C earnings grew +9%.
* Growth was driven by the underwriting result.
* Growth driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence.
* Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets.
* Growth was driven by the financial result.
* Higher unwind of discount of claims reserves, in line with guidance.

* Unfavorable forex impact notably due to USD depreciation vs. EUR.
{{chunk|doc=snjra2xp9r|c=34|p=16}}
====== Underwriting result drivers ======

* The underwriting result improved due to strong volume growth.
* The underwriting result improved due to an enhanced all-year combined ratio.
* The underwriting result improved while enhancing reserve prudence.

{{chunk|doc=snjra2xp9r|c=35|p=16}}
====== Financial result drivers ======

* Investment income increased due to higher volumes.
* Investment income increased due to better reinvestment yields on fixed income assets.
* The unwind of discount of claims reserves was higher, in line with guidance.

{{chunk|doc=snjra2xp9r|c=36|p=16}}
====== Forex impact ======

* There was an unfavorable forex impact, notably due to USD depreciation vs. EUR.


{{chunk|doc=snjra2xp9r|c=37|p=16}}
{{chunk|doc=snjra2xp9r|c=37|p=16}}
====== P&C – Earnings growth from higher underwriting and financial result ======
====== P&C – Earnings growth from higher underwriting and financial result ======


{{fn note|1=1|2=Change at constant FX. 1. Underwriting result includes expenses.}}
{{fn note|1=1|2=Underwriting result includes expenses.}}


=== Life & Health – Strong growth in premiums, positive net flows ===
=== Life & Health – Strong growth in premiums, positive net flows ===


{{chunk|doc=snjra2xp9r|c=38|p=17}}
{{chunk|doc=snjra2xp9r|c=38|p=17}}
====== Life GWP &amp; Other Revenues ======
====== Life & Health premiums and net flows ======

* Life & Health premiums: EUR 49.1bn (+7% LFL)
* Life & Health net flows: EUR +0.2bn

{{chunk|doc=snjra2xp9r|c=39|p=17}}
====== Life GWP & other revenues by lines of business ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 493: Line 513:
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Growth
! class="col-s" style="text-align:right" | Growth
|-
| style="text-align:left" | Total
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|-
|-
| style="text-align:left" | Protection
| style="text-align:left" | Protection
Line 513: Line 538:
| style="text-align:right" | 1.9
| style="text-align:right" | 1.9
| style="text-align:right" | -7%
| style="text-align:right" | -7%
|-
| style="text-align:left" | Total
| style="text-align:right" | 34.5
| style="text-align:right" | 37.5
| style="text-align:right" | +9%
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=39|p=17}}
{{chunk|doc=snjra2xp9r|c=40|p=17}}
====== Health GWP & other revenues by individual and group ======
====== Health GWP & other revenues by individual and group ======


Line 531: Line 551:
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Growth
! class="col-s" style="text-align:right" | Growth
|-
| style="text-align:left" | Total
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|-
|-
| style="text-align:left" | Individual
| style="text-align:left" | Individual
Line 541: Line 566:
| style="text-align:right" | 8.5
| style="text-align:right" | 8.5
| style="text-align:right" | +4%
| style="text-align:right" | +4%
|-
| style="text-align:left" | Total
| style="text-align:right" | 17.5
| style="text-align:right" | 19.0
| style="text-align:right" | +5%
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=40|p=17}}
{{chunk|doc=snjra2xp9r|c=41|p=17}}
====== Flow by segment ======
====== Net flows by segment ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 556: Line 576:
|-
|-
! style="text-align:left" | Segment
! style="text-align:left" | Segment
! class="col-s" style="text-align:right" | Flow (€bn)
! class="col-s" style="text-align:right" | Net flows
|-
|-
| style="text-align:left" | Protection
| style="text-align:left" | Protection
Line 575: Line 595:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=41|p=17}}
{{chunk|doc=snjra2xp9r|c=42|p=17}}
====== Employee Benefits premiums ======
====== Employee Benefits premiums ======


* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]])
* Employee Benefits premiums: EUR 12.9bn (+4% vs. [[Definition:Full year 2024|FY24]]) at constant scope and [[Definition:Foreign exchange|FX]].


{{chunk|doc=snjra2xp9r|c=42|p=17}}
{{chunk|doc=snjra2xp9r|c=43|p=17}}
====== Life & Health – Strong growth in premiums, positive net flows ======
====== Life & Health – Strong growth in premiums, positive net flows ======


{{fn note|1=1|2=Change at constant scope and FX. Including both short-term and long-term Employee Benefits GWP and other revenues.}}
{{fn note|1=1|2=Including both short-term and long-term Employee Benefits GWP and other revenues.}}


=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
=== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===

{{chunk|doc=snjra2xp9r|c=43|p=18}}
====== Currency notation ======

* All figures are in EUR billion.


{{chunk|doc=snjra2xp9r|c=44|p=18}}
{{chunk|doc=snjra2xp9r|c=44|p=18}}
====== PVEP by business mix ======
====== PVEP by business line ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 603: Line 618:
|-
|-
| style="text-align:left" | Protection &amp; Health
| style="text-align:left" | Protection &amp; Health
| rowspan="4" style="text-align:right" | 50.9
| style="text-align:right" |
| style="text-align:right" | 31.4
| style="text-align:right" | 31.4
|-
|-
| style="text-align:left" | Unit-Linked
| style="text-align:left" | Unit-Linked
| style="text-align:right" |
| style="text-align:right" | 8.5
| style="text-align:right" | 8.5
|-
|-
| style="text-align:left" | Capital-light G/A
| style="text-align:left" | Capital-light G/A
| style="text-align:right" |
| style="text-align:right" | 7.8
| style="text-align:right" | 7.8
|-
|-
| style="text-align:left" | Traditional G/A
| style="text-align:left" | Traditional G/A
| style="text-align:right" |
| style="text-align:right" | 1.7
| style="text-align:right" | 1.7
|-
|-
Line 620: Line 638:
|-
|-
| style="text-align:left" | Change
| style="text-align:left" | Change
| style="text-align:right" |
| colspan="2" style="text-align:right" | -2%
| style="text-align:right" | -2%
|-
|-
| style="text-align:left" | Protection &amp; Health change
| style="text-align:left" | Protection &amp; Health change
| style="text-align:right" |
| colspan="2" style="text-align:right" | -4%
| style="text-align:right" | -4%
|-
|-
| style="text-align:left" | Unit-Linked change
| style="text-align:left" | Unit-Linked change
| style="text-align:right" |
| colspan="2" style="text-align:right" | +18%
| style="text-align:right" | +18%
|-
|-
| style="text-align:left" | Capital-light G/A change
| style="text-align:left" | Capital-light G/A change
| style="text-align:right" |
| colspan="2" style="text-align:right" | -10%
| style="text-align:right" | -10%
|-
|-
| style="text-align:left" | Traditional G/A change
| style="text-align:left" | Traditional G/A change
| style="text-align:right" |
| colspan="2" style="text-align:right" | -10%
| style="text-align:right" | -10%
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=45|p=18}}
{{chunk|doc=snjra2xp9r|c=45|p=18}}
====== NB CSM (pre-tax) ======
====== NB CSM (pre-tax) by FY ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t13" class="wikitable fintable"
{| id="t13" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | NB CSM (pre-tax)
| style="text-align:left" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
|-
|-
| style="text-align:left" | Change
| colspan="2" style="text-align:left" | +3%
| style="text-align:right" |
| style="text-align:right" | +3%
|}
|}
</div>
</div>
Line 667: Line 676:
{| id="t14" class="wikitable fintable"
{| id="t14" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | NBV (post-tax)
| style="text-align:left" | 2.3
| style="text-align:right" | 2.3
| style="text-align:right" | 2.2
| style="text-align:right" | 2.2
|-
|-
| style="text-align:left" | Change
| colspan="2" style="text-align:left" | stable
| style="text-align:right" |
| style="text-align:right" | stable
|-
|-
| style="text-align:left" | NBV margin
| style="text-align:left" | NBV margin 4.4%
| style="text-align:right" | 4.4%
| style="text-align:right" | 4.5%
| style="text-align:right" | 4.5%
|}
|}
Line 686: Line 690:


{{chunk|doc=snjra2xp9r|c=47|p=18}}
{{chunk|doc=snjra2xp9r|c=47|p=18}}
====== PVEP, NB CSM, and NBV performance ======
====== Life & Health performance drivers ======


* PVEP was impacted by higher interest rates on discounting despite strong growth in Life volumes.
* PVEP was impacted by higher interest rates on discounting, despite strong growth in Life volumes.
* NB CSM was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits.
* NB CSM was driven by robust Savings & Protection sales; reported growth was impacted by higher interest rates for discounting of future profits.
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.
* NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.


{{chunk|doc=snjra2xp9r|c=48|p=18}}
{{chunk|doc=snjra2xp9r|c=48|p=18}}
====== Reporting basis ======
====== Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ======


{{fn note|1=1|2=Change at constant scope and FX.}}
* All changes are at constant scope and [[Definition:Foreign exchange|FX]].


=== Life & Health – Growth in new business driving Normalized CSM growth ===
=== Life & Health – Growth in new business driving Normalized CSM growth ===


{{chunk|doc=snjra2xp9r|c=49|p=19}}
{{chunk|doc=snjra2xp9r|c=49|p=19}}
====== New business CSM ======
====== Financial Metrics ======


* New business CSM: EUR 2.2bn
* All figures are in EUR billion.


==== Contractual Service Margin rollforward ====
==== Contractual Service Margin rollforward ====
Line 720: Line 724:
! style="text-align:right" | Affiliates, FX &amp; other
! style="text-align:right" | Affiliates, FX &amp; other
! style="text-align:right" | FY25
! style="text-align:right" | FY25
|-
| style="text-align:left" | 33.6
| style="text-align:right" | +2.2
| style="text-align:left" | +1.3
| style="text-align:right" | -3.0
| style="text-align:right" | +0.6
| style="text-align:right" | -0.3
| style="text-align:right" | -1.4
| style="text-align:right" | 33.0
|-
| colspan="8" style="text-align:left" | Normalized CSM growth +2%
|}
|}
</div>
</div>
<tr><td>33.6</td><td>+2.2</td><td>+1.3</td><td>-3.0</td><td>+0.6</td><td>-0.3</td><td>-1.4</td><td>33.0</td></tr>
<tr><td>o/w Life: 25.8</td><td></td><td></td><td></td><td></td><td></td><td></td><td>25.4</td></tr>
<tr><td>o/w Health: 7.7</td><td></td><td></td><td></td><td></td><td></td><td></td><td>7.6</td></tr>
</table>


{{chunk|doc=snjra2xp9r|c=51|p=19}}
{{chunk|doc=snjra2xp9r|c=51|p=19}}
====== CSM breakdown by business line ======

* Life CSM: EUR 25.4bn ([[Definition:Full year 2025|FY25]]) vs EUR 25.8bn ([[Definition:Full year 2024|FY24]])
* Health CSM: EUR 7.6bn (FY25) vs EUR 7.7bn (FY24)

{{chunk|doc=snjra2xp9r|c=52|p=19}}
====== Normalized CSM growth and drivers ======
====== Normalized CSM growth and drivers ======


* Normalized CSM growth: +2%
* Normalized CSM increased by +2%
* Normalized CSM up +2%, with CSM release growth reflecting better margins
* CSM release growth reflects better margins
* New business CSM growth impacted by higher rates
* New business CSM growth was impacted by higher rates
* Economic variance reflects government spreads tightening and positive equity market returns
* Economic variance reflects government spreads tightening and positive equity market returns
* Operating variance driven by better margins and net flows, more than offset by a reduction in the duration of Group Life business in Switzerland
* Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation
* [[Definition:Foreign exchange|FX]] impact mainly from JPY and HKD depreciation


{{chunk|doc=snjra2xp9r|c=52|p=19}}
{{chunk|doc=snjra2xp9r|c=53|p=19}}
====== Contractual Service Margin rollforward ======
====== Contractual Service Margin rollforward ======


Line 744: Line 761:
=== Life & Health – Strong momentum in both short-term and long-term business ===
=== Life & Health – Strong momentum in both short-term and long-term business ===


{{chunk|doc=snjra2xp9r|c=53|p=20}}
{{chunk|doc=snjra2xp9r|c=54|p=20}}
====== Life & Health business overview ======
====== Life & Health gross revenues ======


* Gross revenues: EUR 32,009m in 2023 (reported)
* All figures are in EUR million.
** France: EUR 10,009m
** Europe: EUR 10,009m
** AXA XL: EUR 1,000m
** International: EUR 1,000m
** Asia: EUR 10,000m
** Other: EUR 0m


==== Underlying Earnings ====
==== Underlying Earnings +7% ====


{{chunk|doc=snjra2xp9r|c=54|p=20}}
{{chunk|doc=snjra2xp9r|c=55|p=20}}
====== Underlying Earnings (In Euro million) ======
====== Underlying Earnings waterfall by Step ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t16" class="wikitable fintable"
{| id="t16" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" | Step
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | Value
|-
! style="text-align:left" | Short-term technical margin
! style="text-align:left" | Long-term result incl. CSM release
| style="text-align:left" | FY24
! class="col-s" style="text-align:right" | Financial result
| style="text-align:right" | 3,323
! class="col-s" style="text-align:right" | Tax, FX and others
! class="col-s" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | Short-term technical margin
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | 415
| style="text-align:right" | +60
| style="text-align:left" | +60
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 479
|-
|-
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 2,680
| style="text-align:right" | +156
| style="text-align:left" |
| style="text-align:left" | +156
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 2,804
|-
|-
| style="text-align:left" | Financial result
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" | -11
| style="text-align:right" | -11
| style="text-align:right" |
| style="text-align:right" | 946
|-
|-
| style="text-align:left" | Tax &amp; others
| style="text-align:left" | Tax, FX and others
| style="text-align:right" | -748
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" | -27
| style="text-align:right" | -27
| style="text-align:right" | -728
|-
|-
| style="text-align:left" | Total
| style="text-align:left" | FY25
| style="text-align:right" | 3,323
| style="text-align:left" |
| style="text-align:left" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 3,501
| style="text-align:right" | 3,501
|}
|}
</div>
</div>

{{chunk|doc=snjra2xp9r|c=55|p=20}}
====== Underlying Earnings ======

* [[Definition:Underlying earnings|Underlying Earnings]]: +7%


{{chunk|doc=snjra2xp9r|c=56|p=20}}
{{chunk|doc=snjra2xp9r|c=56|p=20}}
====== in billions ======
====== FY24 vs FY25 Underlying Earnings breakdown (In Euro million) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 821: Line 812:
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change at constant FX
|-
|-
| style="text-align:left" | o/w Life
| style="text-align:left" | Short-term technical margin
| style="text-align:right" | 2.6
| style="text-align:right" | 415
| style="text-align:right" | 2.7
| style="text-align:right" | 479
| style="text-align:right" | +4% vs. FY24
|-
|-
| style="text-align:left" | o/w Health
| style="text-align:left" | Long-term result incl. CSM release
| style="text-align:right" | 0.7
| style="text-align:right" | 2,680
| style="text-align:right" | 0.8
| style="text-align:right" | 2,804
|-
| style="text-align:right" | +17% vs. FY24
| style="text-align:left" | Financial result
| style="text-align:right" | 975
| style="text-align:right" | 946
|-
| style="text-align:left" | Tax &amp; others
| style="text-align:right" | -748
| style="text-align:right" | -728
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=57|p=20}}
{{chunk|doc=snjra2xp9r|c=57|p=20}}
====== Technical Margin and Long-Term Results ======
====== Underlying Earnings by Business Line ======


* Life [[Definition:Underlying earnings|underlying earnings]]: EUR 2.7bn (prior: EUR 2.6bn), +4% vs. [[Definition:Full year 2024|FY24]]
* Short-term technical margin was strong, reflecting underwriting and claims initiatives.
* Health underlying earnings: EUR 0.8bn (prior: EUR 0.7bn), +17% vs. FY24
* Underwriting and claims initiatives more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn).
* Long-term results were higher due to an increase in CSM release (+8%).
* The increase in CSM release reflects growth in the reserve base, including from favorable equity market performance, and better margins.


{{chunk|doc=snjra2xp9r|c=58|p=20}}
{{chunk|doc=snjra2xp9r|c=58|p=20}}
====== Underlying Earnings ======
====== Technical Margin and Long-Term Results ======

* Strong short-term technical margin due to underwriting and claims initiatives
* Impact of legislative change on recoverability of value added tax in Mexico: -EUR 0.1bn
* Higher long-term results from +8% increase in CSM release
* Increase in CSM release reflects growth in reserve base, including from favorable equity market performance, and better margins

{{chunk|doc=snjra2xp9r|c=59|p=20}}
====== Underlying Earnings +7% ======


{{fn note|1=1|2=Change at constant FX.}}
{{fn note|1=1|2=Change at constant FX.}}
Line 850: Line 852:
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===


{{chunk|doc=snjra2xp9r|c=59|p=21}}
{{chunk|doc=snjra2xp9r|c=60|p=21}}
====== Net income by business line ======
====== Net income by business line ======


Line 908: Line 910:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=60|p=21}}
{{chunk|doc=snjra2xp9r|c=61|p=21}}
====== Underlying earnings and net income drivers ======
====== Underlying earnings and holding costs ======


* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses.
* [[Definition:Underlying earnings|Underlying earnings]] showed strong performance from insurance businesses.
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]].
* Holding cost was stable and is expected to remain at the current level in [[Definition:Year 2026|2026]].

* Net income was higher, mainly reflecting higher underlying earnings and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]].
{{chunk|doc=snjra2xp9r|c=62|p=21}}
====== Net income drivers ======

* Net Income was higher, mainly reflecting higher [[Definition:Underlying earnings|underlying earnings]] and the gain from the sale of [[Definition:AXA Investment Managers|AXA IM]].
* Lower financial flows reflected an unfavorable forex impact.
* Lower financial flows reflected an unfavorable forex impact.


==== Underlying earnings per share ====
==== Underlying earnings per share ====


{{chunk|doc=snjra2xp9r|c=61|p=21}}
{{chunk|doc=snjra2xp9r|c=63|p=21}}
====== Underlying earnings per share ======
====== Underlying earnings per share ======


* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in Euro.
* [[Definition:Underlying earnings per share|Underlying earnings per share]] are presented in EUR.


{{chunk|doc=snjra2xp9r|c=62|p=21}}
{{chunk|doc=snjra2xp9r|c=64|p=21}}
====== Underlying earnings per share (In Euro) ======
====== Underlying earnings per share (In Euro) ======


Line 939: Line 945:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=63|p=21}}
{{chunk|doc=snjra2xp9r|c=65|p=21}}
====== Underlying EPS growth drivers ======
====== Underlying EPS growth drivers ======


* [[Definition:Underlying earnings per share|Underlying EPS]] growth: +6% from earnings growth
* [[Definition:Underlying earnings per share|Underlying EPS]] growth included +6% from earnings growth.
* Underlying EPS growth: +3% from [[Definition:Capital management|capital management]]
* Underlying EPS growth included +3% from [[Definition:Capital management|capital management]].
* Underlying EPS growth: -2% from forex
* Underlying EPS growth included -2% from forex.
* Underlying EPS growth: -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to [[Definition:AXA Investment Managers|AXA IM]] sale, related to the timing of anti-dilutive [[Definition:Share buyback|share buyback]]
* Underlying EPS growth included -1% from temporary [[Definition:Earnings dilution|earnings dilution]] due to the timing of the anti-dilutive [[Definition:Share buyback|share buyback]] related to the [[Definition:AXA Investment Managers|AXA IM]] sale.


{{chunk|doc=snjra2xp9r|c=64|p=21}}
{{chunk|doc=snjra2xp9r|c=66|p=21}}
====== Underlying earnings per share ======
====== Underlying earnings per share ======


Line 953: Line 959:


=== Shareholders' Equity ===
=== Shareholders' Equity ===

{{chunk|doc=snjra2xp9r|c=67|p=22}}
====== Shareholders' Equity ======

* Shareholders' Equity is presented in EUR billion.


==== Shareholders' equity ====
==== Shareholders' equity ====


{{chunk|doc=snjra2xp9r|c=65|p=22}}
{{chunk|doc=snjra2xp9r|c=68|p=22}}
====== Shareholders' equity<sup>1</sup> ======
====== Shareholders' equity ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
Line 966: Line 977:
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | HY25
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
| style="text-align:left" | Total
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
|-
| style="text-align:left" | SHE (excl. OCI)
| style="text-align:left" | SHE (excl. OCI)
Line 981: Line 987:
| style="text-align:right" | -7.2
| style="text-align:right" | -7.2
| style="text-align:right" | -6.8
| style="text-align:right" | -6.8
|-
| style="text-align:left" | Shareholders' Equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
| style="text-align:right" | 47.2
|-
|-
| style="text-align:left" | SHE (excl. OCI &amp; undated subordinated debt)
| style="text-align:left" | SHE (excl. OCI &amp; undated subordinated debt)
Line 999: Line 1,010:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=66|p=22}}
{{chunk|doc=snjra2xp9r|c=69|p=22}}
====== Shareholders' equity ======
====== Shareholders' equity ======


Line 1,055: Line 1,066:
=== Higher organic cash remittance and robust cash position at Holding ===
=== Higher organic cash remittance and robust cash position at Holding ===


{{chunk|doc=snjra2xp9r|c=67|p=23}}
{{chunk|doc=snjra2xp9r|c=70|p=23}}
====== Cash remittance and position ======
====== Currency notation ======


* In EUR billion
* All figures are in EUR bn.


==== Net Cash Remittance ====
==== Net Cash Remittance ====


{{chunk|doc=snjra2xp9r|c=68|p=23}}
{{chunk|doc=snjra2xp9r|c=71|p=23}}
====== Net Cash Remittance ======
====== Net Cash Remittance ======


Line 1,070: Line 1,081:
! style="text-align:left" |
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | FY25
|-
|-
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}}
| style="text-align:left" | Proceeds related to in-force treaties{{fn ref|2}}
Line 1,076: Line 1,087:
| style="text-align:right" |
| style="text-align:right" |
|-
|-
| style="text-align:left" | Ordinary cash remittance
| style="text-align:left" | Ordinary remittance
| style="text-align:right" | 7.1
| style="text-align:right" | 7.1
| style="text-align:right" | 7.5
| style="text-align:right" | 7.5
Line 1,082: Line 1,093:
| style="text-align:left" | Total
| style="text-align:left" | Total
| style="text-align:right" | 7.7
| style="text-align:right" | 7.7
| style="text-align:right" | 7.5
| style="text-align:right" | <strong>7.5</strong>
|-
|-
| style="text-align:left" | Remittance ratio{{fn ref|1}}
| style="text-align:left" | Remittance ratio{{fn ref|1}}
Line 1,090: Line 1,101:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=69|p=23}}
{{chunk|doc=snjra2xp9r|c=72|p=23}}
====== Net Cash Remittance ======
====== Net Cash Remittance ======


Line 1,130: Line 1,141:
=== Solvency II at 224% ===
=== Solvency II at 224% ===


{{chunk|doc=snjra2xp9r|c=70|p=24}}
{{chunk|doc=snjra2xp9r|c=73|p=24}}
====== Foreseeable dividends and share buyback provision ======
====== Foreseeable dividends and share buyback provision ======


Line 1,136: Line 1,147:
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn
* Provision for annual [[Definition:Share buyback|share buyback]] for [[Definition:Year 2026|2026]]: EUR -1.25bn


{{chunk|doc=snjra2xp9r|c=71|p=24}}
{{chunk|doc=snjra2xp9r|c=74|p=24}}
====== Eligible Own Funds (EOF) ======
====== Eligible Own Funds (EOF) / Solvency Capital Requirement (SCR) / Solvency II ratio bridge FY24–FY25 ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t24" class="wikitable"
{| id="t24" class="wikitable fintable"
|-
|-
! style="text-align:left" | FY24
! style="text-align:left" |
! style="text-align:left" | Regulatory &amp; model changes
! class="col-s" style="text-align:right" | FY24
! style="text-align:left" | Normalized capital generation
! class="col-s" style="text-align:right" | Regulatory &amp; model changes
! style="text-align:right" | Operating variance
! class="col-s" style="text-align:right" | Normalized capital generation
! style="text-align:right" | Economic variance &amp; FX
! class="col-s" style="text-align:right" | Operating variance
! class="col-s" style="text-align:right" | Economic variance &amp; FX
! style="text-align:left" | Dividend &amp; annual share buyback
! style="text-align:left" | Dividend &amp; annual share buyback
! style="text-align:left" | Management actions, debt &amp; other
! class="col-s" style="text-align:right" | Management actions, debt &amp; other
! style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|}
|-
| style="text-align:left" | Eligible Own Funds (EOF)
</div>
| style="text-align:right" | 55.9

| style="text-align:right" | +0.2
{{chunk|doc=snjra2xp9r|c=72|p=24}}
| style="text-align:right" | +8.8
====== Solvency II ratio movements ======
| style="text-align:right" | -0.4

| style="text-align:right" | -2.1
* Solvency II ratio: 55.9 (reported)
| style="text-align:left" | -6.0 / -0.1
* Solvency II ratio movements: +0.2 from operating return; +8.8 from market impacts; -0.4 from [[Definition:Capital management|capital management]]; -2.1 from regulatory changes; -6.0 from other impacts; -0.1 from [[Definition:Foreign exchange|FX]]
| style="text-align:right" |
* Solvency II ratio at period end: 56.4 (reported)
| style="text-align:right" | 56.4

{{chunk|doc=snjra2xp9r|c=73|p=24}}
====== Solvency II ratio ======

<div style="overflow-x:auto">
{| id="t25" class="wikitable"
|-
|-
! style="text-align:left" | FY24
| style="text-align:left" | Solvency II ratio
! style="text-align:left" | Regulatory &amp; model changes
| style="text-align:right" | 216%
! style="text-align:left" | Normalized capital generation
| style="text-align:right" | +0pt
! style="text-align:right" | Operating variance
| style="text-align:right" | +28pts
! style="text-align:right" | Economic variance &amp; FX
| style="text-align:right" | -1pt
! style="text-align:left" | Dividend &amp; annual share buyback
| style="text-align:right" | +4pts
! style="text-align:left" | Management actions, debt &amp; other
| style="text-align:left" | -24pts
! style="text-align:right" | FY25
| style="text-align:right" | +2pts
| style="text-align:right" | 224%
|-
| style="text-align:left" | Solvency Capital Requirement (SCR)
| style="text-align:right" | 25.9
| style="text-align:right" | 0.0
| style="text-align:right" | +0.6
| style="text-align:right" | 0.0
| style="text-align:right" | -1.2
| style="text-align:left" | 0.0
| style="text-align:right" | -0.2
| style="text-align:right" | 25.2
|}
|}
</div>
</div>


==== Key sensitivities ====
{{chunk|doc=snjra2xp9r|c=74|p=24}}
====== Solvency II ratio evolution ======

* Solvency II ratio was 216%.
* The ratio increased by +28pts due to operating return.
* The ratio decreased by -1pt due to market impacts.
* The ratio increased by +4pts due to [[Definition:Capital management|capital management]].
* The ratio decreased by -24pts due to regulatory changes.
* The ratio increased by +2pts due to other effects.
* The final Solvency II ratio was 224%.


{{chunk|doc=snjra2xp9r|c=75|p=24}}
{{chunk|doc=snjra2xp9r|c=75|p=24}}
====== Solvency Capital Requirement (SCR) ======
====== Solvency II ratio ======


* Solvency II ratio as of December 31, 2025: 224%
<div style="overflow-x:auto">
{| id="t26" class="wikitable"
|-
! style="text-align:left" | FY24
! style="text-align:left" | Regulatory &amp; model changes
! style="text-align:left" | Normalized capital generation
! style="text-align:right" | Operating variance
! style="text-align:right" | Economic variance &amp; FX
! style="text-align:left" | Dividend &amp; annual share buyback
! style="text-align:left" | Management actions, debt &amp; other
! style="text-align:right" | FY25
|}
</div>


{{chunk|doc=snjra2xp9r|c=76|p=24}}
{{chunk|doc=snjra2xp9r|c=76|p=24}}
====== Solvency II ratio bridge ======
====== Impact by sensitivity ======

* Solvency II ratio bridge: 25.9 (start); 0.0 (operating capital generation); +0.6 (market impacts); 0.0 (non-operating items); -1.2 (

==== Key sensitivities ====

{{chunk|doc=snjra2xp9r|c=77|p=24}}
====== Impact by scenario ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t27" class="wikitable fintable"
{| id="t25" class="wikitable fintable"
|-
|-
! style="text-align:left" | Scenario
! style="text-align:left" | Sensitivity
! class="col-s" style="text-align:right" | Impact
! class="col-s" style="text-align:right" | Impact
|-
| style="text-align:left" | Ratio as of December 31, 2025
| style="text-align:right" | 224%
|-
|-
| style="text-align:left" | Interest rate +50bps
| style="text-align:left" | Interest rate +50bps
Line 1,234: Line 1,221:
|-
|-
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}}
| style="text-align:left" | Euro Sovereign spreads +50bps{{fn ref|1}}
| style="text-align:right" | -1 pt
| style="text-align:right" | -7 pts
|-
|-
| style="text-align:left" | Credit migration{{fn ref|2}}
| style="text-align:left" | Credit migration{{fn ref|2}}
| style="text-align:right" | +2 pts
| style="text-align:right" | -4 pts
|-
|-
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) +25%
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) +25%
| style="text-align:right" | -7 pts
| style="text-align:right" | -1 pt
|-
|-
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) -25%
| style="text-align:left" | Listed Equity (excl. PE &amp; Infra) -25%
| style="text-align:right" | -4 pts
| style="text-align:right" | +2 pts
|-
|-
| style="text-align:left" | PE &amp; Infra +25%
| style="text-align:left" | PE &amp; Infra +25%
Line 1,261: Line 1,248:
=== Solvency II – impact of the end of grandfathering period and Solvency II revision ===
=== Solvency II – impact of the end of grandfathering period and Solvency II revision ===


{{chunk|doc=snjra2xp9r|c=78|p=25}}
{{chunk|doc=snjra2xp9r|c=77|p=25}}
====== Solvency II Ratio and Capital Impacts ======
====== Ratio as of 31/12/2025 by impact of the end of grandfathering period and Solvency II revision ======


* Solvency II Ratio as of 31/12/2025: 224%
<div style="overflow-x:auto">
* Impact of the end of the grandfathering period on January 1, [[Definition:Year 2026|2026]]: -10pts, reducing the ratio to 215%
{| id="t28" class="wikitable"
* EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026
|-
* Impact of Solvency II revision, expected to come into effect in 1Q27: +17pts
| style="text-align:left" | Ratio as of 31/12/2025
* No change expected in organic capital generation
| style="text-align:right" | 224%
* Additional capital flexibility
| style="text-align:left" |
|-
| style="text-align:left" | Impact of the end of grandfathering period on January 1, 2026
| style="text-align:right" | -10pts to 215%
| style="text-align:left" | Euro 2.4 billion grandfathered debt no longer eligible as capital from January 1, 2026
|-
| style="text-align:left" | Impact of Solvency II revision to come into effect in 1Q27
| style="text-align:right" | +17pts{{fn ref|1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}
| style="text-align:left" |
|}
</div>
No change expected in organic capital generation<br/>
Additional capital flexibility
</td>
</tr>
</table>
{{fn note|1=1|2=Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date.}}


== Conclusion ==
== Conclusion ==


{{chunk|doc=snjra2xp9r|c=79|p=26}}
{{chunk|doc=snjra2xp9r|c=78|p=26}}
====== Group CEO ======
====== Group CEO ======


Line 1,296: Line 1,267:
=== Conclusion ===
=== Conclusion ===


{{chunk|doc=snjra2xp9r|c=80|p=27}}
{{chunk|doc=snjra2xp9r|c=79|p=27}}
====== Business performance and outlook ======
====== Business performance and outlook ======


* Record results were achieved at the top end of the [[Definition:Target range|target range]] while enhancing reserve prudence.
* Record results were achieved, at the top end of the [[Definition:Target range|target range]], while enhancing reserve prudence.
* All businesses are in excellent shape, delivering strong growth and profitability.
* All businesses are
* The diversified franchise is well-positioned to capture future growth opportunities.
* Foundations are being laid for the next plan, with confidence in delivering sustainable earnings growth.


== Q&A ==
=== Q&A ===


{{chunk|doc=snjra2xp9r|c=81|p=28}}
{{chunk|doc=snjra2xp9r|c=80|p=28}}
====== Date ======
====== Date ======


Line 1,315: Line 1,284:
==== Meet our management ====
==== Meet our management ====


{{chunk|doc=snjra2xp9r|c=82|p=29}}
{{chunk|doc=snjra2xp9r|c=81|p=29}}
====== Investor relations calendar ======
====== Investor calendar ======


* March: Roadshows in Europe and US
* March: Roadshows in Europe and US
Line 1,327: Line 1,296:
==== Contact us ====
==== Contact us ====


{{chunk|doc=snjra2xp9r|c=83|p=29}}
{{chunk|doc=snjra2xp9r|c=82|p=29}}
====== Investor Relations contact ======
====== Investor Relations contact ======


* Investor Relations contact: +33 1 40 75 48 42
* Investor Relations contact number: +33 1 40 75 48 42.
* Investor Relations email: investor.relations@axa.com
* Investor Relations email: investor.relations@axa.com.


==== Follow us ====
==== Follow us ====


{{chunk|doc=snjra2xp9r|c=84|p=29}}
{{chunk|doc=snjra2xp9r|c=83|p=29}}
====== AXA website ======
====== Website information ======


* AXA website: www.axa.com
* AXA's website is www.axa.com.


== Appendices ==
== Appendices ==


=== Contents ===
{{chunk|doc=snjra2xp9r|c=85|p=31}}
====== Appendices overview ======


{{chunk|doc=snjra2xp9r|c=84|p=31}}
* The document includes appendices on: Debt and Invested Assets; Additional P&C disclosures; Additional IFRS17 disclosures.
====== Additional disclosures ======

* Debt and Invested Assets are on p.31.
* Additional P&C disclosures are on p.36.
* Additional IFRS17 disclosures are on p.41.


=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===


{{chunk|doc=snjra2xp9r|c=86|p=32}}
{{chunk|doc=snjra2xp9r|c=85|p=32}}
====== Gross financial debt and maturity breakdown ======
====== Gross financial debt and maturity breakdown as of December 31st, 2025 ======


=== Theme: Gross financial debt and ===
* All figures are in EUR billion.


==== Gross financial debt ====
==== Gross financial debt Contractual maturity breakdown ====


{{chunk|doc=snjra2xp9r|c=87|p=32}}
{{chunk|doc=snjra2xp9r|c=86|p=32}}
====== Debt gearing ======
====== Debt gearing ======


* Debt gearing: 20.6% (prior: 22.3%)
* Debt gearing was 20.6% (prior: 22.3%).


{{chunk|doc=snjra2xp9r|c=88|p=32}}
{{chunk|doc=snjra2xp9r|c=87|p=32}}
====== Gross financial debt (In Euro billion) ======
====== Gross financial debt by tier ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t29" class="wikitable fintable"
{| id="t26" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY24
! class="col-m" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Jan 1st 2026
! class="col-m" style="text-align:right" | Jan 1st 2026
|-
| style="text-align:left" | Total
| style="text-align:right" | 19.2
| style="text-align:right" | 20.3
| style="text-align:right" | 20.3
|-
|-
| style="text-align:left" | Tier 1
| style="text-align:left" | Tier 1
Line 1,391: Line 1,359:
| style="text-align:right" | 3.5
| style="text-align:right" | 3.5
| style="text-align:right" | 5.8
| style="text-align:right" | 5.8
|-
| style="text-align:left" | <strong>Total</strong>
| style="text-align:right" | <strong>19.2</strong>
| style="text-align:right" | <strong>20.3</strong>
| style="text-align:right" | <strong>20.3</strong>
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=89|p=32}}
{{chunk|doc=snjra2xp9r|c=88|p=32}}
====== Gross financial debt details ======
====== Debt maturity and types ======


* End of the grandfathering period
* The grandfathering period ends on January 1, [[Definition:Year 2026|2026]].
* EUR 0.4bn redeemed in Jan [[Definition:Year 2026|2026]]
* EUR 0.4bn will be redeemed in January 2026.
* Debt types include Tier 1, Tier 2, and Senior debt.


{{chunk|doc=snjra2xp9r|c=89|p=32}}
==== Contractual maturity breakdown ====
====== Senior debt, Tier 2, Tier 1 by contractual maturity ======

{{chunk|doc=snjra2xp9r|c=90|p=32}}
====== Contractual maturity breakdown (In Euro billion) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t30" class="wikitable fintable"
{| id="t27" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,425: Line 1,397:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.9
| style="text-align:right" | 1.5
| style="text-align:right" | 1.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
Line 1,435: Line 1,407:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.9
| style="text-align:right" |
| style="text-align:right" | 0.7
| style="text-align:right" | 0.7
| style="text-align:right" | 10.8
| style="text-align:right" | 10.8
| style="text-align:right" |
| style="text-align:right" | 4.6
| style="text-align:right" |
| style="text-align:right" |
|-
|-
Line 1,449: Line 1,421:
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" |
| style="text-align:right" |
|}
|}
</div>
</div>


==== o/w Grandfathered debt (Contractual maturity breakdown) ====
{{chunk|doc=snjra2xp9r|c=91|p=32}}
====== Contractual maturity breakdown ======


{{chunk|doc=snjra2xp9r|c=90|p=32}}
* Grandfathered debt is included in the contractual maturity breakdown.
====== o/w Grandfathered debt (Contractual maturity breakdown) ======

{{chunk|doc=snjra2xp9r|c=92|p=32}}
====== Tier 1 & Tier 2 by 2025, 2026, 2027, 2028, 2029, 2030, 2031-2039, ≥2040, Undated ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t31" class="wikitable fintable"
{| id="t28" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,502: Line 1,471:
==== Economic maturity breakdown ====
==== Economic maturity breakdown ====


{{chunk|doc=snjra2xp9r|c=93|p=32}}
{{chunk|doc=snjra2xp9r|c=91|p=32}}
====== Economic maturity breakdown by senior debt, Tier 2, Tier 1 ======
====== Economic maturity breakdown (In Euro billion) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t32" class="wikitable fintable"
{| id="t29" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,534: Line 1,503:
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
| style="text-align:right" | 2.4
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 2.0
| style="text-align:right" | 2.0
| style="text-align:right" | 0.4
| style="text-align:right" | 6.4
| style="text-align:right" | 6.4
| style="text-align:right" |
| style="text-align:right" | 0.7
| style="text-align:right" |
| style="text-align:right" |
|-
|-
| style="text-align:left" | Tier 1
| style="text-align:left" | Tier 1
| style="text-align:right" | 0.1
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 0.1
| style="text-align:right" |
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.7
| style="text-align:right" |
| style="text-align:right" | 0.4
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | 4.0
| style="text-align:right" | 4.0
| style="text-align:right" |
|}
|}
</div>
</div>


==== o/w Grandfathered debt (Economic maturity breakdown) ====
{{chunk|doc=snjra2xp9r|c=94|p=32}}
====== Grandfathered debt ======


{{chunk|doc=snjra2xp9r|c=92|p=32}}
* o/w Grandfathered debt
====== Grandfathered debt by economic maturity and tier ======

{{chunk|doc=snjra2xp9r|c=95|p=32}}
====== Tier 1 & Tier 2 by economic maturity ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t33" class="wikitable fintable"
{| id="t30" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,605: Line 1,571:
=== General Account Invested Assets ===
=== General Account Invested Assets ===


{{chunk|doc=snjra2xp9r|c=96|p=33}}
{{chunk|doc=snjra2xp9r|c=93|p=33}}
====== General Account invested assets duration gap ======
====== General Account invested assets ======


* [[Definition:Full year 2025|FY25]] Total General Account invested assets Duration gap at -0.4 year
* [[Definition:Full year 2025|FY25]] Total General Account invested assets
* Duration gap at -0.4 year


{{chunk|doc=snjra2xp9r|c=97|p=33}}
{{chunk|doc=snjra2xp9r|c=94|p=33}}
====== FY25 Total General Account invested assets: Euro 450 billion ======
====== FY25 Total General Account invested assets: Euro 450 billion ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t34" class="wikitable"
{| id="t31" class="wikitable fintable"
|-
|-
| style="text-align:left" | Fixed income
| style="text-align:left" | Fixed income
| style="text-align:right" | 77%
|-
|-
| style="text-align:left" | Real estate
| style="text-align:left" | Real estate
| style="text-align:right" | 9%
|-
|-
| style="text-align:left" | Infrastructure equity
| style="text-align:left" | Infrastructure equity
| style="text-align:right" | 2%
|-
|-
| style="text-align:left" | Listed equities
| style="text-align:left" | Listed equities
| style="text-align:right" | 2%
|-
|-
| style="text-align:left" | Private equity and hedge funds
| style="text-align:left" | Private equity and hedge funds
| style="text-align:right" | 5%
|-
|-
| style="text-align:left" | Cash
| style="text-align:left" | Cash
| style="text-align:right" | 4%
|-
|-
| style="text-align:left" | Policy loans
| style="text-align:left" | Policy loans
| style="text-align:right" | 0%
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=98|p=33}}
{{chunk|doc=snjra2xp9r|c=95|p=33}}
====== Invested assets (100%) In Euro billion ======
====== Invested assets (100%) In Euro billion ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t35" class="wikitable fintable"
{| id="t32" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,688: Line 1,662:
</div>
</div>


{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial &amp; Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}}
{{fn note|1=1|2=Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).}}
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}}
{{fn note|1=2|2=Includes hedges. Listed equities excluding hedges at Euro 14 billion.}}
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}}
{{fn note|1=3|2=Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).}}
Line 1,695: Line 1,669:
=== Structured and Private Credit assets ===
=== Structured and Private Credit assets ===


{{chunk|doc=snjra2xp9r|c=99|p=34}}
{{chunk|doc=snjra2xp9r|c=96|p=34}}
====== Invested assets (100%) by Total Structured and Private Credit Assets ======
====== Structured and Private Credit assets ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t36" class="wikitable"
{| id="t33" class="wikitable fintable"
|-
|-
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion
! style="text-align:left" | Invested assets (100%)<br/>In Euro billion
! style="text-align:right" | FY25
! class="col-m" style="text-align:right" | FY25
! style="text-align:right" | % of total G/A{{fn ref|1}} portfolio
! class="col-m" style="text-align:right" | % of total G/A{{fn ref|1}} portfolio
! style="text-align:right" | Comments
! style="text-align:left" | Comments
|-
| style="text-align:left" | Residential Mortgages
| style="text-align:right" | 16
| style="text-align:right" | 4%
| style="text-align:left" | - €6bn Dutch mortgages, NHG guaranteed<br/>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
|-
| style="text-align:left" | CLO &amp; ABS
| style="text-align:right" | 25
| style="text-align:right" | 6%
| style="text-align:left" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:left" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:left" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:left" | - Strong diversification with €8m average ticket<br/>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:left" |
|-
| style="text-align:left" | <strong>Total Structured and Private Credit Assets</strong>
| style="text-align:right" | <strong>69</strong>
| style="text-align:right" | <strong>15%</strong>
| style="text-align:left" | o/w 54% participating
|}
|}
</div>
</div>
<tr><td>Residential Mortgages</td><td>16</td><td>4%</td><td>- €6bn Dutch mortgages, NHG guaranteed<br>- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)</td></tr>
<tr><td>CLO & ABS</td><td>25</td><td>6%</td><td>- 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)</td></tr>
<tr><td>Infrastructure debt</td><td>8</td><td>2%</td><td>- Skewed towards resilient industries (Telecom, Utilities, Transport)</td></tr>
<tr><td>CRE debt</td><td>8</td><td>2%</td><td>- Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV</td></tr>
<tr><td>Mid-Market lending</td><td>10</td><td>2%</td><td>- Strong diversification with €8m average ticket<br>- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation</td></tr>
<tr><td>Other</td><td>2</td><td>0%</td><td></td></tr>
<tr><td><strong>Total Structured and Private Credit Assets</strong></td><td><strong>69</strong></td><td><strong>15%</strong></td><td>o/w 54% participating</td></tr>
</table>


{{fn note|1=1|2=G/A: General Account}}
{{fn note|1=1|2=G/A: General Account}}
Line 1,722: Line 1,723:
==== FY25 Fixed Income Reinvestment ====
==== FY25 Fixed Income Reinvestment ====


{{chunk|doc=snjra2xp9r|c=100|p=35}}
{{chunk|doc=snjra2xp9r|c=97|p=35}}
====== Fixed income reinvestment portfolio ======
====== FY25 fixed income reinvestment allocation ======


* EUR 57bn in fixed income reinvestment
* Government bonds & related comprise 32% of the portfolio with an average rating of AA.
* Investment grade credit comprises 40% of the portfolio with an average rating of A.
* Government bonds & related: 32% of reinvestment, average rating AA
* Investment grade credit: 40% of reinvestment, average rating A
* ABS/CLO/IG fund financing comprises 21% of the portfolio.
* ABS/CLO/IG fund financing: 21% of reinvestment
* Below investment grade credit comprises 7% of the portfolio.
* Below investment grade credit: 7% of reinvestment
* The total reinvestment amount is EUR 57bn.


==== FY25 Fixed Income Reinvestment Yield ====
==== FY25 Fixed Income Reinvestment Yield ====


{{chunk|doc=snjra2xp9r|c=101|p=35}}
{{chunk|doc=snjra2xp9r|c=98|p=35}}
====== Fixed income reinvestment yield by public, private & structured fixed income ======
====== FY25 Fixed Income Reinvestment Yield ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t37" class="wikitable fintable"
{| id="t34" class="wikitable fintable"
|-
|-
! style="text-align:left" | Public fixed income{{fn ref|1}}
! style="text-align:left" | Public fixed income{{fn ref|1}}
Line 1,749: Line 1,750:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=102|p=35}}
{{chunk|doc=snjra2xp9r|c=99|p=35}}
====== FY25 fixed income reinvestment yield ======
====== Fixed income investment details ======


* EUR 57bn fixed income invested at 3.9%
* EUR 57bn fixed income invested at 3.9%
Line 1,757: Line 1,758:
* Gradual shift from alternative total return assets to Private & Structured credit
* Gradual shift from alternative total return assets to Private & Structured credit


{{chunk|doc=snjra2xp9r|c=103|p=35}}
{{chunk|doc=snjra2xp9r|c=100|p=35}}
====== FY25 Fixed Income Reinvestment Yield ======
====== FY25 Fixed Income Reinvestment Yield ======


Line 1,763: Line 1,764:
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}}
{{fn note|1=2|2=Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).}}


=== Contents ===
{{chunk|doc=snjra2xp9r|c=104|p=36}}

{{chunk|doc=snjra2xp9r|c=101|p=36}}
====== Additional disclosures ======
====== Additional disclosures ======


* Additional P&C disclosures are on page 36.
* Debt and Invested Assets are detailed on p.31.
* Additional IFRS17 disclosures are on page 41.
* Additional P&C disclosures are provided on p.36.
* Debt and Invested Assets disclosures are on page 31.
* Additional IFRS17 disclosures are available on p.41.


=== AXA XL Insurance – Large Commercial & Specialty business ===
=== AXA XL Insurance – Large Commercial & Specialty business ===
Line 1,774: Line 1,777:
==== Well diversified across lines of business and geographies ====
==== Well diversified across lines of business and geographies ====


{{chunk|doc=snjra2xp9r|c=105|p=37}}
{{chunk|doc=snjra2xp9r|c=102|p=37}}
====== GWP by line of business ======
====== FY25 GWP by line of business ======


* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by line of business: USD 19bn
<div style="overflow-x:auto">
** Casualty: 35%
{| id="t38" class="wikitable fintable"
** Property: 29%
|-
** Specialty: 19%
| style="text-align:left" | Casualty
** Professional lines: 17%
| style="text-align:right" | 35%
|-
| style="text-align:left" | Property
| style="text-align:right" | 29%
|-
| style="text-align:left" | Specialty
| style="text-align:right" | 19%
|-
| style="text-align:left" | Professional lines{{fn ref|1}}
| style="text-align:right" | 17%
|}
</div>


{{chunk|doc=snjra2xp9r|c=106|p=37}}
{{chunk|doc=snjra2xp9r|c=103|p=37}}
====== GWP by geography ======
====== FY25 GWP by geography ======


* [[Definition:Full year 2025|FY25]] [[Definition:Gross written premiums|GWP]] by geography: USD 19bn
<div style="overflow-x:auto">
** Americas: 46%
{| id="t39" class="wikitable fintable"
** Europe & APAC: 35%
|-
** UK & Lloyds: 19%
| style="text-align:left" | Americas
| style="text-align:right" | 46%
|-
| style="text-align:left" | Europe &amp; APAC
| style="text-align:right" | 35%
|-
| style="text-align:left" | UK &amp; Lloyds
| style="text-align:right" | 19%
|}
</div>


==== Leading market positions across lines ====
==== Leading market positions across lines ====


{{chunk|doc=snjra2xp9r|c=107|p=37}}
{{chunk|doc=snjra2xp9r|c=104|p=37}}
====== Commercial lines market position ======
====== Leading market positions ======


* Top 3 globally in Multinational Programs, Marine, and Fine Art & Specie.
* Top 3 globally
* Multinational Programs
* Marine
* Fine Art & Specie


==== Managing the cycle to deliver consistent profitability ====
==== Managing the cycle to deliver consistent profitability ====


{{chunk|doc=snjra2xp9r|c=108|p=37}}
{{chunk|doc=snjra2xp9r|c=105|p=37}}
====== Profitability vs. Ex-price growth by line of business ======
====== Commercial lines performance by segment ======

* Bubble chart axes: Ex-price growth (%) (x-axis) and Profitability (y-axis).
* Segments shown in the bubble chart:
** Property: high profitability, high ex-price growth
** Specialty
** Casualty
** Professional lines: lower profitability, lower ex-price growth

{{chunk|doc=snjra2xp9r|c=106|p=37}}
====== Managing the cycle to deliver consistent profitability ======


{{fn note|1=1|2=Including Cyber}}
* Profitability vs. Ex-price growth (%)
{{fn note|1=2|2=Source: McKinsey}}
** Professional lines: lower ex-price growth, lower profitability
{{fn note|1=3|2=Source: Aon, Guy Carpenter, and Global Market Insights}}
** Casualty: medium ex-price growth, medium profitability
{{fn note|1=4|2=Source: Industry Research Biz (January 2026)}}
** Specialty (including Cyber): medium-high ex-price growth, medium-high profitability
** Property: high ex-price growth, high profitability


=== P&C – Focus on Reserves ===
=== P&C – Focus on Reserves ===
Line 1,833: Line 1,828:
==== Claims reserves ratio ====
==== Claims reserves ratio ====


{{chunk|doc=snjra2xp9r|c=109|p=38}}
{{chunk|doc=snjra2xp9r|c=107|p=38}}
====== Claims reserves ratio definition ======
====== Claims reserves ratio definition ======


* Net undiscounted claims reserves / Net earned premiums.
* Claims reserves ratio is defined as Net undiscounted claims reserves divided by Net earned premiums.


{{chunk|doc=snjra2xp9r|c=110|p=38}}
{{chunk|doc=snjra2xp9r|c=108|p=38}}
====== Claims reserves ratio (Net undiscounted claims reserves/Net earned premiums) ======
====== Claims reserves ratio ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t40" class="wikitable fintable"
{| id="t35" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,849: Line 1,844:
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22 (IFRS4)
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22 (IFRS17)
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
! style="text-align:left" |
! colspan="5" style="text-align:center" | IFRS4
! colspan="4" style="text-align:center" | IFRS17
|-
|-
| style="text-align:left" | Claims reserves ratio
| style="text-align:left" | Claims reserves ratio
Line 1,874: Line 1,865:
==== Technical reserves ratio ====
==== Technical reserves ratio ====


{{chunk|doc=snjra2xp9r|c=111|p=38}}
{{chunk|doc=snjra2xp9r|c=109|p=38}}
====== Technical reserves ratio definition ======
====== Net undiscounted technical reserves ratio ======


* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.
* The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.


{{chunk|doc=snjra2xp9r|c=112|p=38}}
{{chunk|doc=snjra2xp9r|c=110|p=38}}
====== Technical reserves ratio (Net undiscounted technical reserves/Net earned premiums) ======
====== Technical reserves ratio ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t41" class="wikitable fintable"
{| id="t36" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,890: Line 1,881:
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY20
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY21
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22 (IFRS4)
! class="col-s" style="text-align:right" | FY22
! class="col-s" style="text-align:right" | FY22 (IFRS17)
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY23
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
|-
! style="text-align:left" |
! colspan="5" style="text-align:center" | IFRS4
! colspan="4" style="text-align:center" | IFRS17
|-
|-
| style="text-align:left" | Technical reserves ratio
| style="text-align:left" | Technical reserves ratio
Line 1,917: Line 1,904:
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ===
=== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ===


{{chunk|doc=snjra2xp9r|c=113|p=39}}
{{chunk|doc=snjra2xp9r|c=111|p=39}}
====== Nat Cat Reinsurance Program ======
====== Currency basis ======


* All figures are in EUR.
* All figures are in Euro.


{{chunk|doc=snjra2xp9r|c=112|p=39}}
==== Insurance segment (occurrence protection) ====
====== Capacity & Retention by peril ======

==== Reinsurance segment (illustrative) ====

{{chunk|doc=snjra2xp9r|c=114|p=39}}
====== Alternative Capital & Cat Bonds ======

* Alternative Capital & Cat Bonds

{{chunk|doc=snjra2xp9r|c=115|p=39}}
====== Capacity and Retention by peril ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t42" class="wikitable fintable"
{| id="t37" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 1,944: Line 1,922:
! class="col-s" style="text-align:right" | NA Earthquake
! class="col-s" style="text-align:right" | NA Earthquake
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}}
! class="col-s" style="text-align:right" | Per other perils{{fn ref|3}}
! style="text-align:left" | Reinsurance segment (illustrative) — Alternative Capital &amp; Cat Bonds
|-
|-
| style="text-align:left" | Capacity
| style="text-align:left" | Capacity
Line 1,952: Line 1,931:
| style="text-align:right" | 1.2bn
| style="text-align:right" | 1.2bn
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:left" |
|-
|-
| style="text-align:left" | Retention
| style="text-align:left" | Retention
Line 1,960: Line 1,940:
| style="text-align:right" | 600m{{fn ref|2}}
| style="text-align:right" | 600m{{fn ref|2}}
| style="text-align:right" | 400m
| style="text-align:right" | 400m
| style="text-align:left" |
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=116|p=39}}
{{chunk|doc=snjra2xp9r|c=113|p=39}}
====== Retention levels ======
====== 2026 Simplified Group Nat Cat Reinsurance Program ======


* Stable retention levels maintained in [[Definition:Year 2026|2026]] as in 2025.
* Retention levels are expected to remain stable in [[Definition:Year 2026|2026]], consistent with 2025 levels.


{{chunk|doc=snjra2xp9r|c=117|p=39}}
{{chunk|doc=snjra2xp9r|c=114|p=39}}
====== P&C – 2026 Simplified Group Nat Cat Reinsurance Program ======
====== Reinsurance segment (illustrative) ======


{{fn note|1=1|2=Excludes local reinsurance covers;}}
{{fn note|1=1|2=Excludes local reinsurance covers;}}
Line 1,977: Line 1,958:
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 ===
=== P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026 ===


{{chunk|doc=snjra2xp9r|c=118|p=40}}
{{chunk|doc=snjra2xp9r|c=115|p=40}}
====== Nat Cat cost deviation ======
====== Nat Cat cost deviation ======


* Nat Cat cost deviation in [[Definition:Year 2026|2026]] is presented in EUR billion (net of reinsurance).
* Nat Cat cost deviation is presented in EUR billion, net of reinsurance.


==== Group underlying earnings deviation to average Nat Cat charges in 2026 ====
==== Group underlying earnings deviation to average Nat Cat charges in 2026 ====


{{chunk|doc=snjra2xp9r|c=119|p=40}}
{{chunk|doc=snjra2xp9r|c=116|p=40}}
====== Nat Cat charges deviation ======
====== Net of reinsurance ======


* The table presents Nat Cat charges deviation net of reinsurance, post-tax and pre-tax.
* The data is presented both net of reinsurance, post-tax, and net of reinsurance, pre-tax.


{{chunk|doc=snjra2xp9r|c=120|p=40}}
{{chunk|doc=snjra2xp9r|c=117|p=40}}
====== Deviation by percentile and return period ======
====== Deviation by scenario and percentile ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t43" class="wikitable"
{| id="t38" class="wikitable"
|-
|-
! style="text-align:left" | Percentile
! style="text-align:left" | Scenario
! style="text-align:right" | Return period
! style="text-align:right" | Percentile
! style="text-align:right" | Deviation
! style="text-align:right" | Deviation
|-
|-
| style="text-align:left" | 95th
| style="text-align:left" | 1/20y more severe
| style="text-align:right" | 1/20y (more severe)
| style="text-align:right" | 95th
| style="text-align:right" | €-1.2bn
| style="text-align:right" | €-1.2bn
|-
|-
| style="text-align:left" | 90th
| style="text-align:left" | 1/10y more severe
| style="text-align:right" | 1/10y
| style="text-align:right" | 90th
| style="text-align:right" | €-0.8bn
| style="text-align:right" | €-0.8bn
|-
|-
| style="text-align:left" | 80th
| style="text-align:left" | 1/5y more severe
| style="text-align:right" | 1/5y
| style="text-align:right" | 80th
| style="text-align:right" | €-0.4bn
| style="text-align:right" | €-0.4bn
|-
|-
| style="text-align:left" | 50th
| style="text-align:left" | Median
| style="text-align:right" | Median
| style="text-align:right" | 50th
| style="text-align:right" | €+0.1bn
| style="text-align:right" | €+0.1bn
|-
|-
| style="text-align:left" | 20th
| style="text-align:left" | 1/5y less severe
| style="text-align:right" | 1/5y
| style="text-align:right" | 20th
| style="text-align:right" | €+0.5bn
| style="text-align:right" | €+0.5bn
|-
|-
| style="text-align:left" | 10th
| style="text-align:left" | 1/10y less severe
| style="text-align:right" | 1/10y
| style="text-align:right" | 10th
| style="text-align:right" | €+0.7bn
| style="text-align:right" | €+0.7bn
|-
|-
| style="text-align:left" | 5th
| style="text-align:left" | 1/20y less severe
| style="text-align:right" | 1/20y
| style="text-align:right" | 5th
| style="text-align:right" | €+0.8bn
| style="text-align:right" | €+0.8bn
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=121|p=40}}
{{chunk|doc=snjra2xp9r|c=118|p=40}}
====== Nat Cat charges deviation ======
====== Nat Cat charges deviation ======


Line 2,037: Line 2,018:
==== Average Expected Nat Cat charges ====
==== Average Expected Nat Cat charges ====


{{chunk|doc=snjra2xp9r|c=122|p=40}}
{{chunk|doc=snjra2xp9r|c=119|p=40}}
====== Value & Estimated impact on GEP by year ======
====== Amount & Estimated impact on GEP by year ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t44" class="wikitable"
{| id="t39" class="wikitable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,047: Line 2,028:
! style="text-align:right" | 2026
! style="text-align:right" | 2026
|-
|-
| style="text-align:left" | Value (€bn)
| style="text-align:left" | Amount (€bn)
| style="text-align:right" | 2.6
| style="text-align:right" | 2.6
| style="text-align:right" | 2.7
| style="text-align:right" | 2.7
Line 2,059: Line 2,040:
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}}
{{fn note|1=1|2=Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings}}


=== Contents ===
{{chunk|doc=snjra2xp9r|c=123|p=41}}

{{chunk|doc=snjra2xp9r|c=120|p=41}}
====== Additional disclosures ======
====== Additional disclosures ======


* Debt and Invested Assets are detailed on p.31
* Additional disclosures include Debt and Invested Assets on p.31.
* Additional P&C disclosures are on p.36
* Additional P&C disclosures are on p.36.
* Additional IFRS17 disclosures are on p.41
* Additional IFRS17 disclosures are on p.41.


=== P&C – Margin Analysis ===
=== P&C – Margin Analysis ===
Line 2,070: Line 2,053:
==== Technical Result ====
==== Technical Result ====


{{chunk|doc=snjra2xp9r|c=124|p=42}}
{{chunk|doc=snjra2xp9r|c=121|p=42}}
====== Pre-tax technical result ======
====== Pre-tax technical result ======


* All figures are in EUR million (pre-tax).
* Pre-tax technical result in EUR million.


{{chunk|doc=snjra2xp9r|c=125|p=42}}
{{chunk|doc=snjra2xp9r|c=122|p=42}}
====== Current Accident Year Undiscounted Technical Margin ======
====== Current Accident Year Undiscounted Technical Margin by FY25 ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t45" class="wikitable fintable"
{| id="t40" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! class="col-m" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <strong>Current Accident Year Undiscounted Technical Margin</strong>
| style="text-align:left" | <strong>Current Accident Year Undiscounted Technical Margin</strong>
| style="text-align:right" | 2,778
| style="text-align:right" | 2,778
| style="text-align:right" | +707
| style="text-align:right" | +707
|}
</div>

{{chunk|doc=snjra2xp9r|c=123|p=42}}
====== Gross Earned Premiums and Current Accident Year Undiscounted Combined Ratio ======

<div style="overflow-x:auto">
{| id="t41" class="wikitable fintable"
|-
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:left" | Gross Earned Premiums
Line 2,097: Line 2,088:
| style="text-align:right" | -1.0pt
| style="text-align:right" | -1.0pt
|-
|-
| style="text-align:left" | <em>o/w Nat Cats</em>
| style="text-align:left" | o/w Nat Cats
| style="text-align:right" | <em>3.4%</em>
| style="text-align:right" | 3.4%
| style="text-align:right" | <em>-0.4pt</em>
| style="text-align:right" | -0.4pt
|}
|}
</div>
</div>


{{chunk|doc=snjra2xp9r|c=126|p=42}}
{{chunk|doc=snjra2xp9r|c=124|p=42}}
====== Current Accident Year Discounting by FY25 ======
====== Current Accident Year Discounting ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t46" class="wikitable fintable"
{| id="t42" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,135: Line 2,126:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=127|p=42}}
{{chunk|doc=snjra2xp9r|c=125|p=42}}
====== Prior Years' Reserve Development (PYD) ======
====== Prior Years' Reserve Development (PYD) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t47" class="wikitable fintable"
{| id="t43" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,155: Line 2,146:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=128|p=42}}
{{chunk|doc=snjra2xp9r|c=126|p=42}}
====== FY25 Current Accident Year discount rate sensitivity ======
====== FY25 sensitivity to Current Accident Year discount rate changes ======


<div style="overflow-x:auto">
* [[Definition:Full year 2025|FY25]] sensitivity to Current Accident Year discount rate changes: +25bps results in EUR +0.2bn; -25bps results in EUR -0.2bn.
{| id="t44" class="wikitable"
|-
! style="text-align:left" | +25bps
! style="text-align:right" | -25bps
|-
| style="text-align:left" | €+0.2bn
| style="text-align:right" | €-0.2bn
|}
</div>


==== Financial Result ====
==== Financial Result ====


{{chunk|doc=snjra2xp9r|c=129|p=42}}
{{chunk|doc=snjra2xp9r|c=127|p=42}}
====== Pre-tax results ======
====== Pre-tax results ======


* All figures are in EUR million (pre-tax).
* All figures are in EUR million (pre-tax).


{{chunk|doc=snjra2xp9r|c=130|p=42}}
{{chunk|doc=snjra2xp9r|c=128|p=42}}
====== Investment income ======
====== Investment Income ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t48" class="wikitable fintable"
{| id="t45" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,195: Line 2,195:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=131|p=42}}
{{chunk|doc=snjra2xp9r|c=129|p=42}}
====== Insurance Finance Expenses ======
====== Insurance finance expenses ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t49" class="wikitable fintable"
{| id="t46" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,219: Line 2,219:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=132|p=42}}
{{chunk|doc=snjra2xp9r|c=130|p=42}}
====== Insurance finance expenses ======
====== 2026e Insurance Finance Expenses (pre-tax) by change in 2025 current AY Discount ======


<div style="overflow-x:auto">
* 2026e Insurance Finance Expenses (pre-tax): ~ EUR -1.4bn
{| id="t47" class="wikitable"
* Sensitivity of 2026e Insurance Finance Expenses to changes in 2025 current AY Discount:
|-
** +25bps: ~ EUR -50m
! style="text-align:left" | +25bps
** -25bps: ~ EUR +50m
! style="text-align:right" | -25bps
|-
| style="text-align:left" | ~ €-50m
| style="text-align:right" | ~€+50m
|}
</div>


{{chunk|doc=snjra2xp9r|c=133|p=42}}
{{chunk|doc=snjra2xp9r|c=131|p=42}}
====== Underlying Earnings before tax and Underlying Earnings ======
====== Underlying earnings before tax, tax, affiliates, minority interests & other, and underlying earnings ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t50" class="wikitable fintable"
{| id="t48" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <strong>Underlying Earnings before tax</strong>
| style="text-align:left" | <strong>Underlying Earnings before tax</strong>
Line 2,255: Line 2,261:
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em>
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em>
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | <em>+9%</em>
| style="text-align:right" | +9%
|}
|}
</div>
</div>
Line 2,264: Line 2,270:
=== L&H – Margin Analysis ===
=== L&H – Margin Analysis ===


{{chunk|doc=snjra2xp9r|c=134|p=43}}
{{chunk|doc=snjra2xp9r|c=132|p=43}}
====== Scope impact ======
====== Scope impact ======


* Scope impact is included.
* Includes scope impact.


==== Technical Result ====
==== Technical Result ====


{{chunk|doc=snjra2xp9r|c=135|p=43}}
{{chunk|doc=snjra2xp9r|c=133|p=43}}
====== Pre-tax technical result ======
====== Pre-tax technical result ======


* Pre-tax technical result in EUR million
* Pre-tax technical result (in EUR million):


{{chunk|doc=snjra2xp9r|c=136|p=43}}
{{chunk|doc=snjra2xp9r|c=134|p=43}}
====== Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio ======
====== Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t51" class="wikitable fintable"
{| id="t49" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
Line 2,286: Line 2,292:
! class="col-s" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <b>Short-term Technical Margin</b>
| style="text-align:left" | <strong>Short-term Technical Margin</strong>
| style="text-align:right" | <b>479</b>
| style="text-align:right" | 479
| style="text-align:right" | <b>+60</b>
| style="text-align:right" | +60
|-
|-
| style="text-align:left" | Gross Earned Premiums
| style="text-align:left" | Gross Earned Premiums
Line 2,300: Line 2,306:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=137|p=43}}
{{chunk|doc=snjra2xp9r|c=135|p=43}}
====== Laya recapture ======

* Includes recapture of Laya.

{{chunk|doc=snjra2xp9r|c=136|p=43}}
====== Long-term Technical Margin by CSM release and Technical experience ======
====== Long-term Technical Margin by CSM release and Technical experience ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t52" class="wikitable fintable"
{| id="t50" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! class="col-m" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! class="col-m" style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <b>Long-term Technical Margin</b>
| style="text-align:left" | <strong>Long-term Technical Margin</strong>
| style="text-align:right" | <b>2,804</b>
| style="text-align:right" | 2,804
| style="text-align:right" | <b>+156</b>
| style="text-align:right" | +156
|-
|-
| style="text-align:left" | CSM release
| style="text-align:left" | CSM release
Line 2,324: Line 2,335:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=138|p=43}}
{{chunk|doc=snjra2xp9r|c=137|p=43}}
====== FY25 CSM by interest rates, sovereign spreads, corporate spread, equities ======
====== Technical result adjustments ======

* The technical result includes the recapture of Laya.

{{chunk|doc=snjra2xp9r|c=139|p=43}}
====== FY25 CSM by sensitivities ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t53" class="wikitable"
{| id="t51" class="wikitable fintable"
|-
! style="text-align:left" | Baseline
! class="col-s" style="text-align:right" | 33.3
|-
| style="text-align:left" | Interest rates +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Interest rates -50bps
| style="text-align:right" | 0.6
|-
| style="text-align:left" | Sovereign spreads +50bps
| style="text-align:right" | -1.9
|-
| style="text-align:left" | Sovereign spreads -50bps
| style="text-align:right" | 1.9
|-
| style="text-align:left" | Corporate spread +50bps
| style="text-align:right" | -0.8
|-
| style="text-align:left" | Corporate spread -50bps
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Equities +25%
| style="text-align:right" | 1.8
|-
| style="text-align:left" | Equities -25%
| style="text-align:right" | -2.2
|}
|}
</div>
</div>
(in Euro billion)</caption>
<tr><th></th><th>[[Definition:Full year 2025|FY25]]</th></tr>
<tr><td><b>Baseline</b></td><td>33.3</td></tr>
<tr><td>Interest rates +50bps</td><td>-0.8</td></tr>
<tr><td>Interest rates -50bps</td><td>0.6</td></tr>
<tr><td>Sovereign spreads +50bps</td><td>-1.9</td></tr>
<tr><td>Sovereign spreads -50bps</td><td>1.9</td></tr>
<tr><td>Corporate spread +50bps</td><td>-0.8</td></tr>
<tr><td>Corporate spread -50bps</td><td>0.7</td></tr>
<tr><td>Equities +25%</td><td>1.8</td></tr>
<tr><td>Equities -25%</td><td>-2.2</td></tr>
</table>


==== Financial Result ====
==== Financial Result ====


{{chunk|doc=snjra2xp9r|c=140|p=43}}
{{chunk|doc=snjra2xp9r|c=138|p=43}}
====== Pre-tax result ======
====== Pre-tax result by segment ======


* Pre-tax result (in EUR million, pre-tax)
* Pre-tax result: EUR 7,604m
** France: EUR 2,000m
** Europe: EUR 2,000m
** AXA XL: EUR 1,500m
** Asia: EUR 1,000m
** International: EUR 500m
** [[Definition:AXA Investment Managers|AXA IM]]: EUR 200m
** Other: EUR 400m


{{chunk|doc=snjra2xp9r|c=141|p=43}}
{{chunk|doc=snjra2xp9r|c=139|p=43}}
====== Investment Income (non-VFA only) ======
====== Investment income (non-VFA only) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t54" class="wikitable"
{| id="t52" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <b>Investment Income (non-VFA only)</b>
| style="text-align:left" | <strong>Investment Income (non-VFA only)</strong>
| style="text-align:right" | <b>2,484</b>
| style="text-align:right" | 2,484
| style="text-align:right" | <b>-1</b>
| style="text-align:right" | -1
|-
|-
| style="text-align:left" | FY25 Average Assets
| style="text-align:left" | FY25 Average Assets
Line 2,384: Line 2,412:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=142|p=43}}
{{chunk|doc=snjra2xp9r|c=140|p=43}}
====== Insurance Finance Expenses (non-VFA only) ======
====== Insurance Finance Expenses (non-VFA only) ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t55" class="wikitable"
{| id="t53" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <b>Insurance Finance Expenses (non-VFA only)</b>
| style="text-align:left" | <strong>Insurance Finance Expenses (non-VFA only)</strong>
| style="text-align:right" | <b>-1,538</b>
| style="text-align:right" | -1,538
| style="text-align:right" | <b>-9</b>
| style="text-align:right" | -9
|-
|-
| style="text-align:left" | FY24 Reserves at locked-in rate
| style="text-align:left" | FY24 Reserves at locked-in rate
Line 2,408: Line 2,436:
</div>
</div>


{{chunk|doc=snjra2xp9r|c=143|p=43}}
{{chunk|doc=snjra2xp9r|c=141|p=43}}
====== Underlying earnings before tax and underlying earnings ======
====== Underlying Earnings before tax, Tax, Affiliates, Minority interests & Other, Underlying Earnings ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t56" class="wikitable"
{| id="t54" class="wikitable fintable"
|-
|-
! style="text-align:left" |
! style="text-align:left" |
! style="text-align:right" | FY25
! class="col-s" style="text-align:right" | FY25
! style="text-align:right" | Change
! class="col-s" style="text-align:right" | Change
|-
|-
| style="text-align:left" | <b>Underlying Earnings before tax</b>
| style="text-align:left" | <strong>Underlying Earnings before tax</strong>
| style="text-align:right" | <b>4,229</b>
| style="text-align:right" | 4,229
| style="text-align:right" | <b>+205</b>
| style="text-align:right" | +205
|-
|-
| style="text-align:left" | Tax
| style="text-align:left" | Tax
Line 2,430: Line 2,458:
| style="text-align:right" | -51
| style="text-align:right" | -51
|-
|-
| style="text-align:left" | <b>Underlying Earnings</b>
| style="text-align:left" | <strong>Underlying Earnings</strong>
| style="text-align:right" | <b>3,501</b>
| style="text-align:right" | 3,501
| style="text-align:right" | <b>+219</b>
| style="text-align:right" | +219
|-
|-
| style="text-align:left" | <i>Growth vs. FY24 (at constant FX)</i>
| style="text-align:left" | <em>Growth vs. FY24 (at constant FX)</em>
| style="text-align:right" |
| style="text-align:right" |
| style="text-align:right" | +7%
| style="text-align:right" | +7%
Line 2,442: Line 2,470:
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}
{{fn note|1=1|2=Reinvestment yield on fixed income assets.}}


=== Contents ===
{{chunk|doc=snjra2xp9r|c=144|p=44}}

{{chunk|doc=snjra2xp9r|c=142|p=44}}
====== Additional disclosures ======
====== Additional disclosures ======


* Debt and Invested Assets disclosures are on p.31.
* Additional disclosures include Debt and Invested Assets.
* Additional P&C disclosures are on p.36.
* Additional disclosures include P&C disclosures.
* Additional IFRS17 disclosures are on p.41.
* Additional disclosures include IFRS17 disclosures.


=== Expanding AXA's role in society: AXA for Progress Index ===
=== Expanding AXA's role in society: AXA for Progress Index ===


{{chunk|doc=snjra2xp9r|c=145|p=45}}
{{chunk|doc=snjra2xp9r|c=143|p=45}}
====== Target and 2025 Result by Global Investor, Global Insurer, and Company ======
====== 2025 Result by As a GLOBAL INVESTOR, As a GLOBAL INSURER, As a COMPANY ======


<div style="overflow-x:auto">
<div style="overflow-x:auto">
{| id="t57" class="wikitable"
{| id="t55" class="wikitable"
|-
|-
! colspan="2" style="text-align:center" | As a GLOBAL INVESTOR
! colspan="2" style="text-align:center" | As a GLOBAL INVESTOR
Line 2,501: Line 2,531:
=== Sustainability Performance & Ratings ===
=== Sustainability Performance & Ratings ===


{{chunk|doc=snjra2xp9r|c=146|p=46}}
{{chunk|doc=snjra2xp9r|c=144|p=46}}
====== Sustainability ratings ======
====== Sustainability ratings ======


* Dow Jones Best-in-Class Europe & World indices percentile: 97th in 2025
* S&P Global: 97th percentile in Dow Jones Best-in-Class Europe & World indices for 2025.
* MSCI score: AAA in 2025
* MSCI: AAA score for 2025.
* CDP score: B in 2025
* CDP: B score for 2025.
* Sustainalytics ESG Risk Rating: 17.0 (Low risk) in 2025
* Morningstar Sustainalytics: ESG Risk Rating of 17.0 (Low risk) for 2025.
* FTSE4Good Index Series score: 4.3/5 in 2025
* FTSE Russell: 4.3/5 score in FTSE4Good Index Series for 2025.


{{chunk|doc=snjra2xp9r|c=147|p=46}}
{{chunk|doc=snjra2xp9r|c=145|p=46}}
====== Sustainability Performance & Ratings ======
====== Sustainability Performance & Ratings ======


Line 2,517: Line 2,547:
=== Scope ===
=== Scope ===


{{chunk|doc=snjra2xp9r|c=148|p=47}}
{{chunk|doc=snjra2xp9r|c=146|p=47}}
====== Scope of activities by geography and segment ======
====== Scope of activities by geography and segment ======


* France: includes insurance activities, banking activities, and holding.
* France: includes insurance activities, banking activities, and holding.
* Europe: includes Switzerland (insurance activities); Germany (insurance activities and holding); Belgium and Luxembourg (insurance activities and holding); United Kingdom and Ireland (insurance activities and holding); Spain (insurance activities and holdings); Italy (insurance activities); Prima (insurance activities); and AXA Life Europe (insurance activities).
* Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities).
* AXA XL: includes insurance and reinsurance activities and holding.
* AXA XL: includes insurance and reinsurance activities and holding.
* Asia, Africa & EME-LATAM:
* Asia, Africa & EME-LATAM:
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
** Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024, and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income.
** Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, [[Definition:Underlying earnings|underlying earnings]], and net income.
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), and Egypt (insurance activities and holding) are fully consolidated.
** Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated.
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
** EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
** EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
** EME-LATAM: AXA Mediterranean Holdings.
** AXA Mediterranean Holdings is included.
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
* Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated, and Asian joint ventures which are consolidated under the equity method.
* [[Definition:AXA Investment Managers|AXA Investment Managers]] (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated.
* AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method.


{{chunk|doc=snjra2xp9r|c=149|p=47}}
{{chunk|doc=snjra2xp9r|c=147|p=47}}
====== Accounting standards ======
====== Accounting standards ======


Line 2,541: Line 2,572:
=== Glossary ===
=== Glossary ===


{{chunk|doc=snjra2xp9r|c=150|p=48}}
{{chunk|doc=snjra2xp9r|c=148|p=48}}
====== Glossary of financial terms ======
====== Glossary of financial terms ======


* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%
* Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders
* Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders.
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss representing the estimated profit earned by the insurer for providing insurance services during the reporting period
* CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force
* Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow
* Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow.
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business)
* [[Definition:Gross written premiums|Gross Written Premiums]] and [[Definition:Other revenue|Other Revenues]] ([[Definition:Gross written premiums & other revenues|GWP & Other Revenues]]): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
** Other Revenues represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities)
* Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities).
* New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests.
* New Business Value (NBV): the value of newly issued contracts during the current year
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests
* New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP.
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes, net of reinsurance.
* New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term, discounted at the reference interest rate and representing the Group share.
* Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
** Operating variance is net of reinsurance
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.
* Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term
** PVEP is discounted at the reference interest rate and PVEP is Group share
* Technical experience: consists of the impacts on the [[Definition:Underlying earnings|underlying earnings]] if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses
* Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance

=== Thank you ===

{{chunk|doc=snjra2xp9r|c=151|p=49}}
====== Earnings presentation details ======


* [[Definition:Full year 2025|Full Year 2025]] Earnings presentation was on February 26, [[Definition:Year 2026|2026]].
=== Thank you Full Year 2025 Earnings February 26, 2026 ===

Revision as of 17:02, 22 July 2026

Document info
Document IDsnjra2xp9r
OrganizationAXA
Year2025
PeriodFY
Period labelFY25
Document categoryEarnings presentation
Document nameAXA Full Year 2025 Results Presentation
Publication date2026-02-26
LanguageEnglish
Pages49
Sourceoriginal URL
Transcriptwiki page
Datadata page

This article summarizes AXA's Earnings presentation published on 2026-02-26 (49 pages).

Full Year 2025 Earnings Presentation February 26, 2026

Full Year 2025 Earnings

[c. 1; p. 2]

Legal and cautionary statements
  • Certain statements in this document are forward-looking, identified by words like "expects," "anticipates," "may," "plan," "target," "would," and "could".
  • Statements regarding expected underlying earnings per share (UEPS) growth for 2026 are forward-looking and provide one-off guidance for the last year of the Group’s current strategic plan.
  • Forward-looking statements are based on Management’s current views and intentions, are subject to change, and carry known and unknown risks and uncertainties outside AXA’s control that could cause actual results to differ materially.
  • AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by law.
  • This presentation refers to non-GAAP financial measures (APMs) used by Management for analyzing operating trends, financial performance, and position.
  • Non-GAAP financial measures generally lack standardized meaning and may not be comparable to measures used by other companies.
  • Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, the Group’s consolidated financial statements prepared in accordance with IFRS.
  • "Underlying earnings," UEPS, "underlying return on equity," "combined ratio," and "debt gearing" are APMs as defined by ESMA’s guidelines and AMF’s position statement.
  • Reconciliations of APMs to IFRS financial statements and their calculation methodologies are provided in AXA’s 2025 Activity Report.
  • AXA’s 2025 Activity Report is available on www.axa.com.
  • AXA’s consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to audit completion.

Contents

[c. 2; p. 3]

Presentation contents and speakers
  • FY25 Highlights are on p.04.
  • Thomas Buberl is the Group CEO.
  • FY25 Business Performance is on p.09.
  • Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.
  • FY25 Financial Performance is on p.13.
  • Alban de Mailly Nesle is the Group CFO.

FY25 Highlights

[c. 3; p. 4]

Group CEO
  • Thomas Buberl is the Group CEO.

Full Year 2025 – Excellent performance

[c. 4; p. 5]

Financial performance highlights

[c. 5; p. 5]

Shareholder returns and outlook

[c. 6; p. 5]

Full Year 2025 – Excellent performance
(1) Based on the dividend proposed by AXA's Board of Directors on February 25, 2026 and subject to approval by the Shareholders' Annual General Meeting to be held on April 30, 2026.
(2) Following AXA's Board of Directors' approval on February 25, 2026, and expected to commence as soon as reasonably practicable, subject to market conditions.

Executing the plan on growth, margin and efficiency

[c. 7; p. 6]

Underlying earnings by FY
FY24 FY25 Change
Underlying earnings 8.1 8.4 +6%
Underlying earnings excluding AXA IM +9%

[c. 8; p. 6]

Organic growth, profitability, and efficiency
  • Top line growth: +6% organic.
  • Growth balanced across lines: P&C +5%, Life +9%, Health +5%.
  • Record profitability with further margin expansion in P&C and L&H.
  • Improved efficiency.
  • Continued investments in growth and technology for scaling the business.
  • Consistent earnings growth while enhancing reserve prudence.

[c. 9; p. 6]

Executing the plan on growth, margin and efficiency
(1) Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX.

Diversified franchise, well positioned in an attractive industry

Secular trends fueling demand across businesses

[c. 10; p. 7]

Protection gaps and emerging risks
  • Protection gaps and emerging corporate risks are secular trends fueling demand across businesses.
  • Demographics are driving demand for private retirement and healthcare.

[c. 11; p. 7]

Share by segment
Segment Share
Life 33%
Health 17%
Large & Specialty 17%
SME & Mid-market 16%
Retail 17%

[c. 12; p. 7]

Secular trends fueling demand
  • Secular trends are fueling demand across businesses.

Our right to win

[c. 13; p. 7]

Right to win
  • Leading brand and high customer NPS
  • Strong and diversified distribution
  • Technical expertise in pricing and underwriting risks
  • Scale offering a cost advantage

[c. 14; p. 7]

Our right to win
(1) Pie chart represents FY25 gross written premium split excluding AXA IM and holdings.

Laying the foundation for the next plan

[c. 15; p. 8]

Strategic priorities
  • Clear tech and AI roadmap
  • Driving efficiency
  • Enhancing capital allocation discipline
  • Building resilience
  • Confidence in sustaining earnings growth

FY25 Business Performance

[c. 16; p. 9]

FY25 Business Performance
  • Guillaume Borie is the Global Head of Finance, Strategy, Underwriting, Risk, and Technology.

Strong delivery across our businesses

[c. 17; p. 10]

Gross written premiums & Underlying earnings by geography
Gross written premiums Underlying earnings
France (27% of total GWP1) +6% to €31bn +7% to €2.2bn
Europe (38% of total GWP1) +6% to €43bn +9% to €3.5bn
AXA XL (17% of total GWP1) +4% to €19bn +9% to €1.9bn
Asia, Africa & EME-LATAM (18% of total GWP1) +13% to €20bn +6% to €1.5bn
(1) FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers.

P&C – Strong margins, confidence in sustaining growth

[c. 18; p. 11]

P&C GWP and earnings
  • GWP: EUR 58bn
  • GWP mix includes Retail, SME & Mid-market, and AXA XL (Large & Specialty)
  • Underlying earnings: +9% to EUR 5.9bn

[c. 19; p. 11]

Outlook by business segment
2025 Beyond 2025
Retail and SME & Mid-market Growing volumes while expanding margins Investing to improve customer retention & expanding distribution footprint
AXA XL (Large & Specialty) Profitable growth with stable margins Capitalizing on attractive growth opportunities and continued cycle management

[c. 20; p. 11]

Future strategic focus
  • Continued progress on efficiency
  • Higher investment income
  • Data & AI to further enhance customer experience & technical excellence

[c. 21; p. 11]

P&C – Strong margins, confidence in sustaining growth
(1) Includes AXA XL Re premiums of €2.6bn.
(2) Change FY25 vs. FY24 at constant FX.

L&H – Good momentum, well positioned to capture growth opportunities

[c. 22; p. 12]

GWP by short-term and long-term
Short-term
Long-term
Total GWP €57bn

[c. 23; p. 12]

Underlying earnings

2025 Beyond 2025

[c. 24; p. 12]

Strategic priorities
  • Long-term business: Accelerating net flows in Savings at attractive margins.
  • Long-term business: Capturing savings & retirement opportunity, sourcing best asset management products for customers.
  • Short-term business: Growing technical results while absorbing Mexico VAT impact.
  • Short-term business: Capitalizing on demand for health & protection while further improving margins.
  • Focus on cost reduction.
  • Increasing penetration of Protection riders in Savings offerings.
  • Leveraging AI to reduce claims leakage & improve customer outcomes in Health.

[c. 25; p. 12]

2025 Beyond 2025
(1) 1. Change FY25 vs. FY24 at constant FX.

FY25 Financial Performance

[c. 26; p. 13]

Group CFO
  • Alban de Mailly Nesle is the Group CFO.

P&C – Continued disciplined growth

[c. 27; p. 14]

Currency notation
  • All figures are in EUR billion.

GWP & Other Revenues

[c. 28; p. 14]

GWP & other revenues by segment
Segment FY24 FY25 Change o/w pricing1 o/w volume2
Commercial lines 35.8 +4% +2% +2%
AXA XL Reinsurance 2.6 +8% +0.3% +7%
Retail lines 19.7 +7% +5% +2%
Total 56.5 58.0 +5%

[c. 29; p. 14]

Commercial lines growth drivers
  • Continued pricing momentum and volume growth in Mid-market and SME
  • Growth in lines of business with attractive margins while maintaining focus on retention at AXA XL Insurance
  • Growth supported by alternative capital
  • Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25)

[c. 30; p. 14]

GWP & Other Revenues
(1) Price effect.
(2) Includes exposure adjustments and mix & other effects.

P&C – Delivering further margin expansion while enhancing reserve prudence

Combined ratio

[c. 31; p. 15]

Combined ratio
FY24 FY25
Combined ratio 91.0% 90.6%
Undiscounted CY loss ratio (ex Nat Cat) 67.4% 67.0%
Expense ratio 25.0% 24.8%
Nat Cat 3.8% 3.4%
Prior year reserve development -1.6% -1.1%
Discount -3.6% -3.5%

[c. 32; p. 15]

Combined ratio drivers
  • Undiscounted current year loss ratio improved, excluding Nat Cat.
  • Margin expansion in Commercial lines SME & mid-market business and Personal lines due to favorable pricing.
  • AXA XL Insurance margins stable at attractive levels due to disciplined cycle management.
  • Expense ratio improved due to efficiency measures, while investing in growth initiatives and technology.

[c. 33; p. 15]

Nat Cat and reserve development
  • Nat Cat charges were below the normalized load.
  • Lower reliance on prior year reserve development.
  • Reserve prudence enhanced during a favorable year.

P&C – Earnings growth from higher underwriting and financial result

[c. 34; p. 16]

P&C earnings overview
  • P&C earnings increased by EUR 0.2bn to EUR 4.2bn.
  • This growth was driven by higher underwriting results and a higher financial result.

[c. 35; p. 16]

Underlying earnings by step
Step Value
FY24 5,510
Volume growth ( Underwriting result1) +292
Margin improvement +189
Investment income ( Financial result) +435
Insurance finance expenses -235
Tax -169
Affiliates, FX & other -150
FY25 5,872

[c. 36; p. 16]

P&C earnings growth drivers
  • P&C earnings grew +9%.
  • Growth driven by a better underwriting result from strong volume growth and an improved all-year combined ratio, while enhancing reserve prudence.
  • Increase in investment income reflects higher volumes and better reinvestment yields on fixed income assets.
  • Higher unwind of discount of claims reserves, in line with guidance.
  • Unfavorable forex impact notably due to USD depreciation vs. EUR.

[c. 37; p. 16]

P&C – Earnings growth from higher underwriting and financial result
(1) Underwriting result includes expenses.

Life & Health – Strong growth in premiums, positive net flows

[c. 38; p. 17]

Life & Health premiums and net flows
  • Life & Health premiums: EUR 49.1bn (+7% LFL)
  • Life & Health net flows: EUR +0.2bn

[c. 39; p. 17]

Life GWP & other revenues by lines of business
FY24 FY25 Growth
Total 34.5 37.5 +9%
Protection 17.3 +11%
Unit-Linked 9.3 +13%
Capital light G/A 9.0 +7%
Traditional G/A 1.9 -7%

[c. 40; p. 17]

Health GWP & other revenues by individual and group
FY24 FY25 Growth
Total 17.5 19.0 +5%
Individual 10.5 +6%
Group 8.5 +4%

[c. 41; p. 17]

Net flows by segment
Segment Net flows
Protection +4.9
Health +2.7
Unit-Linked +1.5
Capital light G/A +1.2
Traditional G/A -5.0

[c. 42; p. 17]

Employee Benefits premiums
  • Employee Benefits premiums: EUR 12.9bn (+4% vs. FY24) at constant scope and FX.

[c. 43; p. 17]

Life & Health – Strong growth in premiums, positive net flows
(1) Including both short-term and long-term Employee Benefits GWP and other revenues.

Life & Health – Strong volume growth in Savings and Protection impacted by higher interest rates on discounting

[c. 44; p. 18]

PVEP by business line
FY24 FY25
Protection & Health 31.4
Unit-Linked 8.5
Capital-light G/A 7.8
Traditional G/A 1.7
Total 50.9 49.4
Change -2%
Protection & Health change -4%
Unit-Linked change +18%
Capital-light G/A change -10%
Traditional G/A change -10%

[c. 45; p. 18]

NB CSM (pre-tax) by FY
FY24 FY25
2.2 2.2
+3%

[c. 46; p. 18]

NBV (post-tax) by FY
FY24 FY25
2.3 2.2
stable
NBV margin 4.4% 4.5%

[c. 47; p. 18]

Life & Health performance drivers
  • PVEP was impacted by higher interest rates on discounting, despite strong growth in Life volumes.
  • NB CSM was driven by robust Savings & Protection sales; reported growth was impacted by higher interest rates for discounting of future profits.
  • NBV was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France.

[c. 48; p. 18]

Reporting basis
  • All changes are at constant scope and FX.

Life & Health – Growth in new business driving Normalized CSM growth

[c. 49; p. 19]

Financial Metrics
  • All figures are in EUR billion.

Contractual Service Margin rollforward

[c. 50; p. 19]

Contractual Service Margin rollforward (In Euro billion)
FY24 New business CSM Underlying return on in-force CSM release Economic variance Operating variance Affiliates, FX & other FY25
33.6 +2.2 +1.3 -3.0 +0.6 -0.3 -1.4 33.0
Normalized CSM growth +2%

[c. 51; p. 19]

CSM breakdown by business line
  • Life CSM: EUR 25.4bn (FY25) vs EUR 25.8bn (FY24)
  • Health CSM: EUR 7.6bn (FY25) vs EUR 7.7bn (FY24)

[c. 52; p. 19]

Normalized CSM growth and drivers
  • Normalized CSM increased by +2%
  • CSM release growth reflects better margins
  • New business CSM growth was impacted by higher rates
  • Economic variance reflects government spreads tightening and positive equity market returns
  • Operating variance driven by better margins and net flows, offset by a reduction in the duration of Group Life business in Switzerland
  • FX impact mainly from JPY and HKD depreciation

[c. 53; p. 19]

Contractual Service Margin rollforward
(1) Change at constant scope and FX.

Life & Health – Strong momentum in both short-term and long-term business

[c. 54; p. 20]

Life & Health gross revenues
  • Gross revenues: EUR 32,009m in 2023 (reported)
    • France: EUR 10,009m
    • Europe: EUR 10,009m
    • AXA XL: EUR 1,000m
    • International: EUR 1,000m
    • Asia: EUR 10,000m
    • Other: EUR 0m

Underlying Earnings +7%

[c. 55; p. 20]

Underlying Earnings waterfall by Step
Step Value
FY24 3,323
Short-term technical margin +60
Long-term result incl. CSM release +156
Financial result -11
Tax, FX and others -27
FY25 3,501

[c. 56; p. 20]

FY24 vs FY25 Underlying Earnings breakdown (In Euro million)
FY24 FY25
Short-term technical margin 415 479
Long-term result incl. CSM release 2,680 2,804
Financial result 975 946
Tax & others -748 -728

[c. 57; p. 20]

Underlying Earnings by Business Line
  • Life underlying earnings: EUR 2.7bn (prior: EUR 2.6bn), +4% vs. FY24
  • Health underlying earnings: EUR 0.8bn (prior: EUR 0.7bn), +17% vs. FY24

[c. 58; p. 20]

Technical Margin and Long-Term Results
  • Strong short-term technical margin due to underwriting and claims initiatives
  • Impact of legislative change on recoverability of value added tax in Mexico: -EUR 0.1bn
  • Higher long-term results from +8% increase in CSM release
  • Increase in CSM release reflects growth in reserve base, including from favorable equity market performance, and better margins

[c. 59; p. 20]

Underlying Earnings +7%
(1) Change at constant FX.

Growth in net income reflecting higher earnings & the gain from the sale of AXA IM

[c. 60; p. 21]

Net income by business line
FY24 FY25 Change
Property & Casualty 5.5 5.9 +9%
Life & Health 3.3 3.5 +7%
Asset Management 0.4 0.2 -57%
Holdings & other -1.2 -1.2 -
Underlying earnings 8.1 8.4 +6%
Non-financial flows -0.5 +2.1
o/w capital gains from AXA IM disposal - +2.2
Financial flows (incl. RCG) +0.3 -0.7
Net income 7.9 9.8 +26%

[c. 61; p. 21]

Underlying earnings and holding costs
  • Underlying earnings showed strong performance from insurance businesses.
  • Holding cost was stable and is expected to remain at the current level in 2026.

[c. 62; p. 21]

Net income drivers
  • Net Income was higher, mainly reflecting higher underlying earnings and the gain from the sale of AXA IM.
  • Lower financial flows reflected an unfavorable forex impact.

Underlying earnings per share

[c. 63; p. 21]

Underlying earnings per share

[c. 64; p. 21]

Underlying earnings per share (In Euro)
FY24 FY25 Change
3.59 3.86 +8%

[c. 65; p. 21]

Underlying EPS growth drivers

[c. 66; p. 21]

Underlying earnings per share
(1) Change at constant FX for underlying earnings and net income. Change on reported basis for underlying earnings per share.

Shareholders' Equity

[c. 67; p. 22]

Shareholders' Equity
  • Shareholders' Equity is presented in EUR billion.

Shareholders' equity

[c. 68; p. 22]

Shareholders' equity
FY24 HY25 FY25
SHE (excl. OCI) 58.0 52.7 54.0
Net OCI -8.1 -7.2 -6.8
Shareholders' Equity 49.9 45.5 47.2
SHE (excl. OCI & undated subordinated debt) 53.2 47.0 49.4
Debt gearing 20.6% 23.4% 22.3%
Underlying ROE 15.2% 17.5% 16.0%

[c. 69; p. 22]

Shareholders' equity
FY24 to FY25 HY25 to FY25
Opening Shareholders' equity 49.9 45.5
Change in Net OCI 1.3 0.4
Net income for the period 9.8 5.9
Dividend -4.6 -
Annual share buyback -1.2 -
Anti-dilutive share buyback following the sale of AXA IM -3.5 -3.5
Undated subordinated debt (including interest charges) -0.3 -1.2
Forex -3.5 -0.1
Other -0.6 0.3
Closing Shareholders' equity 47.2 47.2
(1) Shareholders' equity Group share. Full Year 2025 Earnings

Higher organic cash remittance and robust cash position at Holding

[c. 70; p. 23]

Currency notation
  • All figures are in EUR bn.

Net Cash Remittance

[c. 71; p. 23]

Net Cash Remittance
FY24 FY25
Proceeds related to in-force treaties2 0.6
Ordinary remittance 7.1 7.5
Total 7.7 7.5
Remittance ratio1 82% 82%

[c. 72; p. 23]

Net Cash Remittance
FY24 Cash position 4.0
Net cash remittance from subsidiaries +7.5
Dividend -4.6
Annual share buyback -1.2
Anti-dilutive share buyback following the sale of AXA IM -3.5
Holding costs and interest expenses -1.3
Change in net debt +1.6
M&A and other +3.1
FY25 Cash position 5.6
(1) Based on ordinary cash remittance of Euro 7.1 billion in FY24 and Euro 7.5 billion in FY25.
(2) €0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe.

Solvency II at 224%

[c. 73; p. 24]

Foreseeable dividends and share buyback provision

[c. 74; p. 24]

Eligible Own Funds (EOF) / Solvency Capital Requirement (SCR) / Solvency II ratio bridge FY24–FY25
FY24 Regulatory & model changes Normalized capital generation Operating variance Economic variance & FX Dividend & annual share buyback Management actions, debt & other FY25
Eligible Own Funds (EOF) 55.9 +0.2 +8.8 -0.4 -2.1 -6.0 / -0.1 56.4
Solvency II ratio 216% +0pt +28pts -1pt +4pts -24pts +2pts 224%
Solvency Capital Requirement (SCR) 25.9 0.0 +0.6 0.0 -1.2 0.0 -0.2 25.2

Key sensitivities

[c. 75; p. 24]

Solvency II ratio
  • Solvency II ratio as of December 31, 2025: 224%

[c. 76; p. 24]

Impact by sensitivity
Sensitivity Impact
Interest rate +50bps +2 pts
Interest rate -50bps -1 pt
Corporate spreads +50bps -1 pt
Euro Sovereign spreads +50bps1 -7 pts
Credit migration2 -4 pts
Listed Equity (excl. PE & Infra) +25% -1 pt
Listed Equity (excl. PE & Infra) -25% +2 pts
PE & Infra +25% +14 pts
PE & Infra -25% -19 pts
Inflation swap curve +50bps -5 pts
(1) Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures).
(2) Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches).

Solvency II – impact of the end of grandfathering period and Solvency II revision

[c. 77; p. 25]

Solvency II Ratio and Capital Impacts
  • Solvency II Ratio as of 31/12/2025: 224%
  • Impact of the end of the grandfathering period on January 1, 2026: -10pts, reducing the ratio to 215%
  • EUR 2.4bn of grandfathered debt will no longer be eligible as capital from January 1, 2026
  • Impact of Solvency II revision, expected to come into effect in 1Q27: +17pts
  • No change expected in organic capital generation
  • Additional capital flexibility

Conclusion

[c. 78; p. 26]

Group CEO
  • Thomas Buberl is the Group CEO.

Conclusion

[c. 79; p. 27]

Business performance and outlook
  • Record results were achieved, at the top end of the target range, while enhancing reserve prudence.
  • All businesses are

Q&A

[c. 80; p. 28]

Date

AXA Investor Relations – Keep in touch

Meet our management

[c. 81; p. 29]

Investor calendar
  • March: Roadshows in Europe and US
  • May 5: 1Q25 Activity Indicators in Paris
  • June 2: BNP Paribas Exane CEO Conference in Paris
  • June 2-4: Goldman Sachs European Financials Conference in Zurich
  • July 31: HY26 Earnings Release in Paris
  • September 21: AXA Investor Day in London

Contact us

[c. 82; p. 29]

Investor Relations contact
  • Investor Relations contact number: +33 1 40 75 48 42.
  • Investor Relations email: investor.relations@axa.com.

Follow us

[c. 83; p. 29]

Website information
  • AXA's website is www.axa.com.

Appendices

Contents

[c. 84; p. 31]

Additional disclosures
  • Debt and Invested Assets are on p.31.
  • Additional P&C disclosures are on p.36.
  • Additional IFRS17 disclosures are on p.41.

Gross financial debt and maturity breakdown as of December 31st, 2025

[c. 85; p. 32]

Gross financial debt and maturity breakdown as of December 31st, 2025

Theme: Gross financial debt and

Gross financial debt Contractual maturity breakdown

[c. 86; p. 32]

Debt gearing
  • Debt gearing was 20.6% (prior: 22.3%).

[c. 87; p. 32]

Gross financial debt by tier
FY24 FY25 Jan 1st 2026
Tier 1 4.8 4.6 3.2
Tier 2 10.8 12.2 11.3
Senior debt 3.5 3.5 5.8
Total 19.2 20.3 20.3

[c. 88; p. 32]

Debt maturity and types
  • The grandfathering period ends on January 1, 2026.
  • EUR 0.4bn will be redeemed in January 2026.
  • Debt types include Tier 1, Tier 2, and Senior debt.

[c. 89; p. 32]

Senior debt, Tier 2, Tier 1 by contractual maturity
2025 2026 2027 2028 2029 2030 2031-2039 ≥2040 Undated
Senior debt 0.9 1.5 0.5
Tier 2 0.5 0.7 10.8 4.6
Tier 1 0.7

o/w Grandfathered debt (Contractual maturity breakdown)

[c. 90; p. 32]

o/w Grandfathered debt (Contractual maturity breakdown)
2025 2026 2027 2028 2029 2030 2031-2039 ≥2040 Undated
Tier 1 - - - - - - - - 1.4
Tier 2 - - - - - 0.7 - 0.2 -

Economic maturity breakdown

[c. 91; p. 32]

Economic maturity breakdown (In Euro billion)
2025 2026 2027 2028 2029 2030 2031-2039 ≥2040 Undated
Senior debt 1.5 0.5
Tier 2 0.1 2.4 0.5 2.0 0.4 6.4 0.7
Tier 1 0.1 0.1 0.9 4.0

o/w Grandfathered debt (Economic maturity breakdown)

[c. 92; p. 32]

Grandfathered debt by economic maturity and tier
2025 2026 2027 2028 2029 2030 2031-2039 ≥2040 Undated
Tier 1 - 0.1 - 0.1 - - 0.4 - 0.8
Tier 2 - - - - - 0.7 0.2 - -
(1,2) 1. Nominal debt. 2. In January 2026, AXA has called (i) the remaining T2 GF £139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF €250m perpetual callable 2010 floating issued January 2005.
(3) 3. Economic maturity is taking into account the first date of step up calls on institutionally placed subordinated debt. For Solvency 2 RT1 debt, that has no step-up, the undated nature of the instrument is retained for the purpose of this diagram. This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable. Such decision will depend on several factors, including our capital and liquidity position and the refinancing economics at the prevailing time.

General Account Invested Assets

[c. 93; p. 33]

General Account invested assets
  • FY25 Total General Account invested assets
  • Duration gap at -0.4 year

[c. 94; p. 33]

FY25 Total General Account invested assets: Euro 450 billion
Fixed income 77%
Real estate 9%
Infrastructure equity 2%
Listed equities 2%
Private equity and hedge funds 5%
Cash 4%
Policy loans 0%

[c. 95; p. 33]

Invested assets (100%) In Euro billion
FY25 %
Fixed income 345 77%
o/w Government bonds 167 37%
o/w Corporate bonds and loans 121 27%
o/w Other fixed income 1 56 13%
Real estate 41 9%
Infrastructure equity 10 2%
Listed equities 2 10 2%
Private equity and hedge funds 3 23 5%
Cash 19 4%
Policy loans 2 0%
Total Insurance Invested Assets 4 450 100%
(1) Other fixed income includes Asset Backed Securities (Euro 25 billion), Residential Loans (Euro 16 billion), Commercial & Agricultural Loans (Euro 7 billion) and Agency Pools (Euro 8 billion).
(2) Includes hedges. Listed equities excluding hedges at Euro 14 billion.
(3) Includes Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).
(4) Please refer to the financial supplement for more details.

Structured and Private Credit assets

[c. 96; p. 34]

Structured and Private Credit assets
Invested assets (100%)
In Euro billion
FY25 % of total G/A1 portfolio Comments
Residential Mortgages 16 4% - €6bn Dutch mortgages, NHG guaranteed
- €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
CLO & ABS 25 6% - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
Infrastructure debt 8 2% - Skewed towards resilient industries (Telecom, Utilities, Transport)
CRE debt 8 2% - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
Mid-Market lending 10 2% - Strong diversification with €8m average ticket
- Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
Other 2 0%
Total Structured and Private Credit Assets 69 15% o/w 54% participating
(1) G/A: General Account

Investment portfolio – Fixed Income reinvestment

FY25 Fixed Income Reinvestment

[c. 97; p. 35]

FY25 fixed income reinvestment allocation
  • EUR 57bn in fixed income reinvestment
  • Government bonds & related: 32% of reinvestment, average rating AA
  • Investment grade credit: 40% of reinvestment, average rating A
  • ABS/CLO/IG fund financing: 21% of reinvestment
  • Below investment grade credit: 7% of reinvestment

FY25 Fixed Income Reinvestment Yield

[c. 98; p. 35]

FY25 Fixed Income Reinvestment Yield
Public fixed income1 Private & Structured fixed income2 Total fixed income
3.5% 4.7% 3.9%

[c. 99; p. 35]

Fixed income investment details
  • EUR 57bn fixed income invested at 3.9%
  • Average duration of 9 years
  • Includes EUR 19.7bn of Private & Structured Credit invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY)
  • Gradual shift from alternative total return assets to Private & Structured credit

[c. 100; p. 35]

FY25 Fixed Income Reinvestment Yield
(1) Government and Corporate bonds and related.
(2) Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid).

Contents

[c. 101; p. 36]

Additional disclosures
  • Debt and Invested Assets are detailed on p.31.
  • Additional P&C disclosures are provided on p.36.
  • Additional IFRS17 disclosures are available on p.41.

AXA XL Insurance – Large Commercial & Specialty business

Well diversified across lines of business and geographies

[c. 102; p. 37]

FY25 GWP by line of business
  • FY25 GWP by line of business: USD 19bn
    • Casualty: 35%
    • Property: 29%
    • Specialty: 19%
    • Professional lines: 17%

[c. 103; p. 37]

FY25 GWP by geography
  • FY25 GWP by geography: USD 19bn
    • Americas: 46%
    • Europe & APAC: 35%
    • UK & Lloyds: 19%

Leading market positions across lines

[c. 104; p. 37]

Leading market positions
  • Top 3 globally
  • Multinational Programs
  • Marine
  • Fine Art & Specie

Managing the cycle to deliver consistent profitability

[c. 105; p. 37]

Commercial lines performance by segment
  • Bubble chart axes: Ex-price growth (%) (x-axis) and Profitability (y-axis).
  • Segments shown in the bubble chart:
    • Property: high profitability, high ex-price growth
    • Specialty
    • Casualty
    • Professional lines: lower profitability, lower ex-price growth

[c. 106; p. 37]

Managing the cycle to deliver consistent profitability
(1) Including Cyber
(2) Source: McKinsey
(3) Source: Aon, Guy Carpenter, and Global Market Insights
(4) Source: Industry Research Biz (January 2026)

P&C – Focus on Reserves

Claims reserves ratio

[c. 107; p. 38]

Claims reserves ratio definition
  • Claims reserves ratio is defined as Net undiscounted claims reserves divided by Net earned premiums.

[c. 108; p. 38]

Claims reserves ratio
FY18 FY19 FY20 FY21 FY22 (IFRS4) FY22 (IFRS17) FY23 FY24 FY25
Claims reserves ratio 179% 185% 193% 188% 189% 198% 195% 180% 175%

Technical reserves ratio

[c. 109; p. 38]

Net undiscounted technical reserves ratio
  • The technical reserves ratio is calculated as Net undiscounted technical reserves divided by Net earned premiums.

[c. 110; p. 38]

Technical reserves ratio
FY18 FY19 FY20 FY21 FY22 (IFRS4) FY22 (IFRS17) FY23 FY24 FY25
Technical reserves ratio 213% 227% 233% 226% 227% 234% 232% 216% 210%
(1) Includes net undiscounted claims reserves and unearned premium reserves.

P&C – 2026 Simplified Group Nat Cat Reinsurance Program

[c. 111; p. 39]

Currency basis
  • All figures are in Euro.

[c. 112; p. 39]

Capacity & Retention by peril
EU Windstorm Europe Flood Europe Earthquake NA Hurricane NA Earthquake Per other perils3 Reinsurance segment (illustrative) — Alternative Capital & Cat Bonds
Capacity 4.0bn 2.1bn 2.1bn 1.2bn 1.2bn
Retention 600m 450m 400m 600m2 600m2 400m

[c. 113; p. 39]

2026 Simplified Group Nat Cat Reinsurance Program
  • Retention levels are expected to remain stable in 2026, consistent with 2025 levels.

[c. 114; p. 39]

P&C – 2026 Simplified Group Nat Cat Reinsurance Program
(1) Excludes local reinsurance covers;
(2) Varying retention between MX and NA (400m MX, 600m NA);
(3) Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils. Capacity varies by peril type.

P&C – AXA Group earnings deviation with different levels of Nat Cat cost in 2026

[c. 115; p. 40]

Nat Cat cost deviation
  • Nat Cat cost deviation is presented in EUR billion, net of reinsurance.

Group underlying earnings deviation to average Nat Cat charges in 2026

[c. 116; p. 40]

Net of reinsurance
  • The data is presented both net of reinsurance, post-tax, and net of reinsurance, pre-tax.

[c. 117; p. 40]

Deviation by scenario and percentile
Scenario Percentile Deviation
1/20y more severe 95th €-1.2bn
1/10y more severe 90th €-0.8bn
1/5y more severe 80th €-0.4bn
Median 50th €+0.1bn
1/5y less severe 20th €+0.5bn
1/10y less severe 10th €+0.7bn
1/20y less severe 5th €+0.8bn

[c. 118; p. 40]

Nat Cat charges deviation
  • Negative deviation in approximately 40% of cases for more severe years.
  • Positive deviation in approximately 60% of cases for less severe years.

Average Expected Nat Cat charges

[c. 119; p. 40]

Amount & Estimated impact on GEP by year
2025 2026
Amount (€bn) 2.6 2.7
Estimated impact on GEP ca. 4.5% ca. 4.5%
(1) Natural catastrophe cost defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance. Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance). Full Year 2025 Earnings

Contents

[c. 120; p. 41]

Additional disclosures
  • Additional disclosures include Debt and Invested Assets on p.31.
  • Additional P&C disclosures are on p.36.
  • Additional IFRS17 disclosures are on p.41.

P&C – Margin Analysis

Technical Result

[c. 121; p. 42]

Pre-tax technical result
  • Pre-tax technical result in EUR million.

[c. 122; p. 42]

Current Accident Year Undiscounted Technical Margin by FY25
FY25 Change
Current Accident Year Undiscounted Technical Margin 2,778 +707

[c. 123; p. 42]

Gross Earned Premiums and Current Accident Year Undiscounted Combined Ratio
Gross Earned Premiums 57,656 +6%
Current Accident Year Undiscounted Combined Ratio 95.2% -1.0pt
o/w Nat Cats 3.4% -0.4pt

[c. 124; p. 42]

Current Accident Year Discounting
FY25 Change
Current Accident Year Discounting 2,009 +115
Discounting Ratio (in Combined Ratio points) -3.5% +0.0pt
Current Accident Year Net Claims reserves €19.0bn
Duration 4.0 years
Current Accident Year Discount rate 2.8%

[c. 125; p. 42]

Prior Years' Reserve Development (PYD)
FY25 Change
Prior Years' Reserve Development (PYD) 622 -341
PYD ratio -1.1% +0.7pt

[c. 126; p. 42]

FY25 sensitivity to Current Accident Year discount rate changes
+25bps -25bps
€+0.2bn €-0.2bn

Financial Result

[c. 127; p. 42]

Pre-tax results
  • All figures are in EUR million (pre-tax).

[c. 128; p. 42]

Investment Income
FY25 Change
Investment Income 3,988 +435
FY25 Average Assets €115bn
Asset book yield 3.5%
FY25 Reinvestment yield1 4.3%

[c. 129; p. 42]

Insurance finance expenses
FY25 Change
Insurance Finance Expenses -1,358 -235
FY24 Reserves at locked-in rate €71bn
Liability book yield 1.9%

[c. 130; p. 42]

2026e Insurance Finance Expenses (pre-tax) by change in 2025 current AY Discount
+25bps -25bps
~ €-50m ~€+50m

[c. 131; p. 42]

Underlying earnings before tax, tax, affiliates, minority interests & other, and underlying earnings
FY25 Change
Underlying Earnings before tax 8,040 +681
Tax -2,060 -169
Affiliates, Minority interests & Other -108 -10
Underlying Earnings 5,872 +501
Growth vs. FY24 (at constant FX) +9%
(1) Reinvestment yield on fixed income assets.
(2) Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve.

L&H – Margin Analysis

[c. 132; p. 43]

Scope impact
  • Includes scope impact.

Technical Result

[c. 133; p. 43]

Pre-tax technical result
  • Pre-tax technical result (in EUR million):

[c. 134; p. 43]

Short-term Technical Margin by Gross Earned Premiums and All Year Combined Ratio
FY25 Change
Short-term Technical Margin 479 +60
Gross Earned Premiums 17,416 +10%
All Year Combined Ratio 97.2% -0.1pts

[c. 135; p. 43]

Laya recapture
  • Includes recapture of Laya.

[c. 136; p. 43]

Long-term Technical Margin by CSM release and Technical experience
FY25 Change
Long-term Technical Margin 2,804 +156
CSM release 2,954 +215
Technical experience -150 -58

[c. 137; p. 43]

FY25 CSM by interest rates, sovereign spreads, corporate spread, equities
Baseline 33.3
Interest rates +50bps -0.8
Interest rates -50bps 0.6
Sovereign spreads +50bps -1.9
Sovereign spreads -50bps 1.9
Corporate spread +50bps -0.8
Corporate spread -50bps 0.7
Equities +25% 1.8
Equities -25% -2.2

Financial Result

[c. 138; p. 43]

Pre-tax result by segment
  • Pre-tax result: EUR 7,604m
    • France: EUR 2,000m
    • Europe: EUR 2,000m
    • AXA XL: EUR 1,500m
    • Asia: EUR 1,000m
    • International: EUR 500m
    • AXA IM: EUR 200m
    • Other: EUR 400m

[c. 139; p. 43]

Investment income (non-VFA only)
FY25 Change
Investment Income (non-VFA only) 2,484 -1
FY25 Average Assets €98bn
Asset book yield 2.5%
FY25 Reinvestment yield1 3.8%

[c. 140; p. 43]

Insurance Finance Expenses (non-VFA only)
FY25 Change
Insurance Finance Expenses (non-VFA only) -1,538 -9
FY24 Reserves at locked-in rate €62bn
Liability book yield 2.5%

[c. 141; p. 43]

Underlying Earnings before tax, Tax, Affiliates, Minority interests & Other, Underlying Earnings
FY25 Change
Underlying Earnings before tax 4,229 +205
Tax -800 65
Affiliates, Minority interests & Other 72 -51
Underlying Earnings 3,501 +219
Growth vs. FY24 (at constant FX) +7%
(1) Reinvestment yield on fixed income assets.

Contents

[c. 142; p. 44]

Additional disclosures
  • Additional disclosures include Debt and Invested Assets.
  • Additional disclosures include P&C disclosures.
  • Additional disclosures include IFRS17 disclosures.

Expanding AXA's role in society: AXA for Progress Index

[c. 143; p. 45]

2025 Result by As a GLOBAL INVESTOR, As a GLOBAL INSURER, As a COMPANY
As a GLOBAL INVESTOR As a GLOBAL INSURER As a COMPANY
Target 2025 Result Target 2025 Result Target 2025 Result
€5bn2 in climate transition financing per year €6.4bn €6bn3 in P&C GWP to support transition underwriting (cumulative 2024-2026) €4.6bn >80,0006(footnote: Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.) AXA Group employees trained on climate adaptation by 2026 46,420
>€500m2 in community resilience financing per year >20,0004 climate adaptation solutions & services (cumulative 2024-2026) Target revised in 2025 19,698 Cumulative 2024-2025 Contribute to Net-Zero -50%7(footnote: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.) by 2030 in absolute carbon emissions and offset of residual emissions8(footnote: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).) -64% Reduction against 2019
€1.4bn >20m5(footnote: Low-income to mass market segments in emerging markets and modest income segments in mature markets.) inclusive insurance customers by 2026 20.6m 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 56%
(1) AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026.
(2) Scope: corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2030.
(3) Scope: AXA France, AXA Germany, AXA Switzerland, AXA UK & Ireland, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Unit: Gross Written Premiums (GWP); Timeframe: cumulative 2024-2026.
(4) Scope: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL; Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaption solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from >9,000 to >20,000.
(5) Low-income to mass market segments in emerging markets and modest income segments in mature markets.
(6) Number of employees who have been trained on climate change adaptation, completing a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026.
(7) Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030.
(8) Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage).

Sustainability Performance & Ratings

[c. 144; p. 46]

Sustainability ratings
  • S&P Global: 97th percentile in Dow Jones Best-in-Class Europe & World indices for 2025.
  • MSCI: AAA score for 2025.
  • CDP: B score for 2025.
  • Morningstar Sustainalytics: ESG Risk Rating of 17.0 (Low risk) for 2025.
  • FTSE Russell: 4.3/5 score in FTSE4Good Index Series for 2025.

[c. 145; p. 46]

Sustainability Performance & Ratings
(1) The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares). Results as of February 6th, 2026.

Scope

[c. 146; p. 47]

Scope of activities by geography and segment
  • France: includes insurance activities, banking activities, and holding.
  • Europe: includes Switzerland (insurance activities), Germany (insurance activities and holding), Belgium and Luxembourg (insurance activities and holding), United Kingdom and Ireland (insurance activities and holding), Spain (insurance activities and holdings), Italy (insurance activities), Prima (insurance activities), and AXA Life Europe (insurance activities).
  • AXA XL: includes insurance and reinsurance activities and holding.
  • Asia, Africa & EME-LATAM:
    • Asia: Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings are fully consolidated.
    • Asia: China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S, and India (Life activities disposed on March 11, 2024 and holding) businesses are consolidated under the equity method and contribute only to NBV, PVEP, underlying earnings, and net income.
    • Africa: Morocco (insurance activities and holding), Nigeria (insurance activities and holding), Egypt (insurance activities and holding) are fully consolidated.
    • EME-LATAM: Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding), and Türkiye (insurance activities and holding) are fully consolidated.
    • EME-LATAM: Russia (Reso) (insurance activities) is consolidated under the equity method and contributes only to net income.
    • AXA Mediterranean Holdings is included.
  • Transversal & Other: includes AXA Assistance, AXA Liabilities Managers, AXA, and other Central Holdings.
  • AXA Investment Managers (until July 1, 2025): includes AXA Investment Managers, Select (previously Architas), and Capza which are fully consolidated.
  • AXA Investment Managers (until July 1, 2025): Asian joint ventures are consolidated under the equity method.

[c. 147; p. 47]

Accounting standards
  • All comparative figures going back to 2023 are under IFRS17/9 accounting standards, effective January 1, 2023, unless otherwise specified.
  • Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4.

Glossary

[c. 148; p. 48]

Glossary of financial terms
  • Capital-light G/A products: encompass all products with no guarantees, with guarantees at maturity only, or with guarantees equal to or lower than 0%.
  • Contractual Service Margin (CSM): a component of the carrying amount of asset or liability for a group of insurance contracts representing the unearned profit to be recognized as services are provided to policyholders.
  • CSM release: a portion of CSM stock net of reinsurance at the end of the defined period flowing through profit and loss, representing the estimated profit earned by the insurer for providing insurance services during the reporting period.
  • Economic variance: corresponds to the variance of the year-end CSM arising from changes in market conditions, net of the underlying return on in-force.
  • Financial result: consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder’s equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow.
  • Gross Written Premiums and Other Revenues (GWP & Other Revenues): represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business).
  • Other Revenues: represent premiums and fees collected on activities other than insurance (i.e., banking, services, and asset management activities).
  • New Business Value (NBV): the value of newly issued contracts during the current year, consisting of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period (carried by Life entities, considering expected renewals), (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes, and (vi) minority interests.
  • New Business Contractual Service Margin (NB CSM): a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided.
  • New Business Value margin (NBV margin): ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP.
  • Operating variance: the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes, net of reinsurance.
  • Present value of expected premiums (PVEP): the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term, discounted at the reference interest rate and representing the Group share.
  • Technical experience: consists of the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses.
  • Underlying return on in-force: represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance.

Thank you Full Year 2025 Earnings February 26, 2026